<SEC-DOCUMENT>0001104659-20-076057.txt : 20200623
<SEC-HEADER>0001104659-20-076057.hdr.sgml : 20200623
<ACCEPTANCE-DATETIME>20200623162015
ACCESSION NUMBER:		0001104659-20-076057
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		21
CONFORMED PERIOD OF REPORT:	20200623
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200623
DATE AS OF CHANGE:		20200623

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HEALTHPEAK PROPERTIES, INC.
		CENTRAL INDEX KEY:			0000765880
		STANDARD INDUSTRIAL CLASSIFICATION:	REAL ESTATE INVESTMENT TRUSTS [6798]
		IRS NUMBER:				330091377
		STATE OF INCORPORATION:			MD
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08895
		FILM NUMBER:		20982107

	BUSINESS ADDRESS:	
		STREET 1:		1920 MAIN STREET
		STREET 2:		SUITE 1200
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614
		BUSINESS PHONE:		949-407-0700

	MAIL ADDRESS:	
		STREET 1:		1920 MAIN STREET
		STREET 2:		SUITE 1200
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HCP, INC.
		DATE OF NAME CHANGE:	20070911

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTH CARE PROPERTY INVESTORS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2023139d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:hcp="http://hcpi.com/20200623">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" /></head>
<!-- Field: Set; Name: xdx; ID: xdx_021_US%2DGAAP%2D2019 -->
<!-- Field: Set; Name: xdx; ID: xdx_03D_hcp_hcpi.com_20200623 -->
<!-- Field: Set; Name: xdx; ID: xdx_041_20200622_20200623 -->
<!-- Field: Set; Name: xdx; ID: xdx_05B_edei%2D%2DEntityCentralIndexKey_0000765880 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
  <ix:hidden>
    <ix:nonNumeric contextRef="From2020-06-22to2020-06-23" name="dei:EntityCentralIndexKey">0000765880</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-06-22to2020-06-23" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
    </ix:hidden>
  <ix:references>
    <link:schemaRef xlink:href="hcp-20200623.xsd" xlink:type="simple" />
    </ix:references>
  <ix:resources>
    <xbrli:context id="From2020-06-22to2020-06-23">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-22</xbrli:startDate>
        <xbrli:endDate>2020-06-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    </ix:resources>
  </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 6.5in">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES<br />
</b>SECURITIES AND EXCHANGE COMMISSION</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt; text-transform: uppercase"><b>Washington</b></span><b><span style="font-size: 10pt">,
D.C. 20549</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_900_edei--DocumentType_c20200622__20200623_zkwLZrBwsAX1"><ix:nonNumeric contextRef="From2020-06-22to2020-06-23" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT<br />
</b><span style="font-size: 10pt">Pursuant to Section&#160;13 or 15(d)<br />
of the Securities Exchange Act of 1934</span><b><br />
</b><span style="font-size: 10pt">Date of Report (Date of earliest event reported): <span id="xdx_907_edei--DocumentPeriodEndDate_c20200622__20200623_zKfBWIDsKfG8"><ix:nonNumeric contextRef="From2020-06-22to2020-06-23" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">June
23, 2020</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 1.5in">&#160;</p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90D_edei--EntityRegistrantName_c20200622__20200623_zVDjFzJ11Wod"><b><ix:nonNumeric contextRef="From2020-06-22to2020-06-23" name="dei:EntityRegistrantName">Healthpeak Properties, Inc.</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact Name of Registrant as Specified
in its Charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="text-align: center; width: 33%"><span style="font-size: 10pt"><b><span id="xdx_909_edei--EntityIncorporationStateCountryCode_c20200622__20200623_zZ7bwICyOAXh"><ix:nonNumeric contextRef="From2020-06-22to2020-06-23" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Maryland</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; width: 34%"><span style="font-size: 10pt"><b><span id="xdx_90C_edei--EntityFileNumber_c20200622__20200623_z6kVK08ajmY9"><ix:nonNumeric contextRef="From2020-06-22to2020-06-23" name="dei:EntityFileNumber">001-08895</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; width: 33%"><span style="font-size: 10pt"><b><span id="xdx_90D_edei--EntityTaxIdentificationNumber_c20200622__20200623_zoemYQO9kcre"><ix:nonNumeric contextRef="From2020-06-22to2020-06-23" name="dei:EntityTaxIdentificationNumber">33-0091377</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: top">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(State or other Jurisdiction</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>of Incorporation)</b></p>

</td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Commission</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>File Number)</b></p></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(I.R.S. Employer</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Identification No.)</b></p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_901_edei--EntityAddressAddressLine1_c20200622__20200623_zPIFiV2WuIV2"><ix:nonNumeric contextRef="From2020-06-22to2020-06-23" name="dei:EntityAddressAddressLine1">1920 Main Street</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressAddressLine2_c20200622__20200623_zI8jczF4ooR1"><ix:nonNumeric contextRef="From2020-06-22to2020-06-23" name="dei:EntityAddressAddressLine2">Suite 1200</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90C_edei--EntityAddressCityOrTown_c20200622__20200623_zvTZG81sdIji"><ix:nonNumeric contextRef="From2020-06-22to2020-06-23" name="dei:EntityAddressCityOrTown">Irvine</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressStateOrProvince_c20200622__20200623_zdFRdPVkwSV"><ix:nonNumeric contextRef="From2020-06-22to2020-06-23" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric></span> <span id="xdx_908_edei--EntityAddressPostalZipCode_c20200622__20200623_zOfbyFmqO592"><ix:nonNumeric contextRef="From2020-06-22to2020-06-23" name="dei:EntityAddressPostalZipCode">92614</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Address of principal executive offices)
(Zip Code)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_90F_edei--CityAreaCode_c20200622__20200623_zTfBSQ6vPNkd"><ix:nonNumeric contextRef="From2020-06-22to2020-06-23" name="dei:CityAreaCode">949</ix:nonNumeric></span>) <span id="xdx_902_edei--LocalPhoneNumber_c20200622__20200623_z2RWMp8AQ3X1"><ix:nonNumeric contextRef="From2020-06-22to2020-06-23" name="dei:LocalPhoneNumber">407-0700</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Registrant&#8217;s telephone number,
including area code)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>N/A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Former Name or Former Address, if Changed
Since Last Report)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 30px"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_900_edei--WrittenCommunications_c20200622__20200623_zxd2v0KTk6Zg"><ix:nonNumeric contextRef="From2020-06-22to2020-06-23" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Written communications pursuant to Rule&#160;425
    under the Securities Act (17 CFR 230.425)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 30px"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_902_edei--SolicitingMaterial_c20200622__20200623_ztguh9QDFQ4k"><ix:nonNumeric contextRef="From2020-06-22to2020-06-23" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Soliciting material pursuant to Rule&#160;14a-12
    under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 30px"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_909_edei--PreCommencementTenderOffer_c20200622__20200623_zdoPsGlxKwMh"><ix:nonNumeric contextRef="From2020-06-22to2020-06-23" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to
    Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 30px; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_907_edei--PreCommencementIssuerTenderOffer_c20200622__20200623_zypydJ7RKF5c"><ix:nonNumeric contextRef="From2020-06-22to2020-06-23" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications
    pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 33%; text-align: center"><span style="font-size: 10pt">Title of each class</span></td>
    <td style="width: 34%; text-align: center"><span style="font-size: 10pt">Trading symbol(s)</span></td>
    <td style="width: 33%; text-align: center"><span style="font-size: 10pt">Name of each exchange on which registered</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span id="xdx_90A_edei--Security12bTitle_c20200622__20200623_z0VNORjV6Q1i" style="font-size: 10pt"><ix:nonNumeric contextRef="From2020-06-22to2020-06-23" name="dei:Security12bTitle">Common stock, $1.00 par value</ix:nonNumeric></span></td>
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_904_edei--TradingSymbol_c20200622__20200623_zZIzcb2xBQRa"><ix:nonNumeric contextRef="From2020-06-22to2020-06-23" name="dei:TradingSymbol">PEAK</ix:nonNumeric></span></span></td>
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_90C_edei--SecurityExchangeName_c20200622__20200623_zSo9tMXRdSLd"><ix:nonNumeric contextRef="From2020-06-22to2020-06-23" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The New York Stock Exchange</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 95%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">Emerging growth company</span></td>
    <td style="width: 5%; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20200622__20200623_zZei92Kd1cUe"><ix:nonNumeric contextRef="From2020-06-22to2020-06-23" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 8.01&#160;Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline">Notes Offering</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On June 23, 2020, Healthpeak
Properties,&#160;Inc., a Maryland corporation (the &#8220;Company&#8221;), completed its underwritten offering (the
&#8220;Offering&#8221;) of $600,000,000 aggregate principal amount of the Company&#8217;s 2.875% Senior Notes due 2031 (the
&#8220;2031 Notes&#8221;). The net proceeds from the Offering, after deducting the underwriting discount but before deducting
estimated offering expenses payable by the Company, are approximately $590,850,000, which the Company intends to use (i) to
fund the redemption, prior to their stated maturity date, of all $300,000,000 aggregate principal amount of its 3.15% senior
notes due August 2022 that are outstanding, and the payment of accrued interest and related fees, premiums and expenses in
connection therewith and (ii) to fund the purchase price for its previously announced tender offer to purchase for cash a
portion of its 4.250% senior notes due November 2023 and the payment of accrued interest and related fees, premiums and
expenses in connection therewith. The Company intends to use any remaining net proceeds for general corporate purposes,
including repayment of any outstanding borrowings under its revolving credit facility (without any permanent reductions in
the commitments thereunder) and/or to repay any outstanding commercial paper.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The 2031 Notes are governed by the terms
of the Indenture, dated November 19, 2012 (the &#8220;Base Indenture&#8221;), between the Company and The Bank of New York Mellon
Trust Company, N.A., as trustee (the &#8220;Trustee&#8221;), which was filed as Exhibit&#160;4.1 to the Company&#8217;s Current
Report on Form 8-K filed with the Commission on November 19, 2012, as supplemented by the Tenth Supplemental Indenture, dated as
of June 23, 2020 (the &#8220;Supplemental Indenture&#8221;), between the Company and the Trustee, which is filed as Exhibit&#160;4.1
to this Current Report on Form&#160;8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The 2031 Notes will mature on January 15,
2031 and the Company will pay interest on the 2031 Notes semi-annually in arrears on January 15 and July 15, beginning on January
15, 2021.&#160;The 2031 Notes will be the Company&#8217;s senior unsecured obligations and will be equal in right of payment with
all of the Company&#8217;s existing and future senior indebtedness. The 2031 Notes will be effectively junior to all existing and
future secured indebtedness to the extent of the collateral securing that indebtedness.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Prior to October 15, 2030, the Company may
redeem all or part of the 2031 Notes at any time or from time to time in part at its option at a redemption price equal to the
greater of: (i)&#160;100% of the principal amount of the 2031 Notes being redeemed on that redemption date, or (ii)&#160;the sum
of the present values of the remaining scheduled payments of principal and interest on the 2031 Notes being redeemed (exclusive
of interest accrued to, but excluding, the date of redemption) that would be due if such Notes matured on October 15, 2030, discounted
to the date of redemption on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate
plus 35 basis points, plus accrued and unpaid interest on the 2031 Notes being redeemed to, but excluding, the date of redemption.
In addition, on or after October 15, 2030, the Company may at its option redeem the 2031 Notes at any time in whole or from time
to time in part at a redemption price equal to 100% of the principal amount of the 2031 Notes to be redeemed, plus accrued and
unpaid interest to, but excluding, the date of redemption.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The 2031 Notes have been registered under
the Securities Act of 1933, as amended, pursuant to an effective Registration Statement on Form&#160;S-3 (333-225318), originally
filed with the Commission on May 31, 2018.&#160; The description of the Base Indenture, the Supplemental Indenture and the 2031
Notes are summaries and are qualified in their entirety by the terms of the Base Indenture, the Supplemental Indenture and the
form of the 2031 Notes. Copies of the Supplemental Indenture and the form of the 2031 Notes are filed as exhibits hereto, and a
copy of the Base Indenture has been previously filed, and each is incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline">Tender Offer</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On June 23, 2020, the Company announced
the early tender results and pricing for its previously announced tender offer to purchase for cash up to an aggregate principal
amount of $250,000,000 (the &#8220;Aggregate Maximum Tender Amount&#8221;) of its 4.250% Senior Notes due 2023 (the &#8220;2023
Notes&#8221;). The tender offer is being made exclusively pursuant to an offer to purchase, dated June 9, 2020, as amended on June
9, 2020, which set forth the terms and conditions of the tender offer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; text-align: center; margin-top: 12pt; margin-bottom: 6pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In order to receive additional consideration
for tendering early, holders of Notes must have validly tendered and not validly withdrawn their Notes prior to or at 5:00 p.m.,
New York City Time, on June&#160;22, 2020 (the &#8220;Early Tender Time&#8221;). At the Early Tender Time, holders had validly
tendered and not validly withdrawn approximately $264,517,000 of the $550 million aggregate principal amount outstanding of the
2023 Notes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Because the aggregate principal amount of
the 2023 Notes validly tendered and not validly withdrawn exceeds the Aggregate Maximum Tender Amount, the Company will not accept
for purchase all of the 2023 Notes that have been validly tendered and not validly withdrawn and will only accept for purchase
the Aggregate Maximum Tender Amount of those Notes. Accordingly, the 2023 Notes validly tendered and not validly withdrawn will
be subject to proration. The Company will use a proration rate of approximately 95% for the 2023 Notes. The 2023 Notes tendered
by a holder will be multiplied by the proration rate and then rounded down to the nearest $1,000 increment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Since the Tender Offer for the 2023 Notes
was fully subscribed as of the Early Tender Time, the Company will not accept for purchase any Notes validly tendered after the
Early Tender Time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The tender offer will expire at 12:00 midnight,
New York City Time, at the end of July 7, 2020, unless earlier terminated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Copies of the press releases announcing
the early tender results and pricing, respectively, of the tender offer, are attached hereto as Exhibits 99.1 and 99.2 and are
incorporated in this Item 8.01 by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; text-align: center; margin-top: 12pt; margin-bottom: 6pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01&#160; Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits.&#160; The following exhibits are being filed herewith:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 93.6%; border-collapse: collapse; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 10%"><span style="font-size: 10pt"><b>No.</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 88%; text-align: center"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
<tr>
    <td style="vertical-align: top"><a href="tm2023139d1_ex4-1.htm"><span style="font-size: 10pt">4.1</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2023139d1_ex4-1.htm"><span style="font-size: 10pt">Tenth Supplemental Indenture, dated as of June 23, 2020, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee </span></a></td></tr>
<tr>
    <td style="vertical-align: top"><a href="tm2023139d1_ex4-1.htm"><span style="font-size: 10pt">4.2</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2023139d1_ex4-1.htm"><span style="font-size: 10pt">Form&#160;of 2.875% Senior Notes due 2031 (included in Exhibit 4.1)</span></a></td></tr>
<tr>
    <td style="vertical-align: top"><a href="tm2023139d1_ex5-1.htm"><span style="font-size: 10pt">5.1</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2023139d1_ex5-1.htm"><span style="font-size: 10pt">Opinion of Ballard Spahr LLP</span></a></td></tr>
<tr>
    <td style="vertical-align: top"><a href="tm2023139d1_ex5-2.htm"><span style="font-size: 10pt">5.2</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2023139d1_ex5-2.htm"><span style="font-size: 10pt">Opinion of Skadden, Arps, Slate, Meagher&#160;&#38; Flom LLP</span></a></td></tr>
<tr>
    <td style="vertical-align: top"><a href="tm2023139d1_ex8-1.htm"><span style="font-size: 10pt">8.1</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2023139d1_ex8-1.htm"><span style="font-size: 10pt">Opinion of Skadden, Arps, Slate, Meagher&#160;&#38; Flom LLP regarding tax matters</span></a></td></tr>
<tr>
    <td style="vertical-align: top"><a href="tm2023139d1_ex5-1.htm"><span style="font-size: 10pt">23.1</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2023139d1_ex5-1.htm"><span style="font-size: 10pt">Consent of Ballard Spahr LLP (included in Exhibit&#160;5.1)</span></a></td></tr>
<tr>
    <td style="vertical-align: top"><a href="tm2023139d1_ex5-2.htm"><span style="font-size: 10pt">23.2</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2023139d1_ex5-2.htm"><span style="font-size: 10pt">Consent of Skadden, Arps, Slate, Meagher&#160;&#38; Flom LLP (included in Exhibit&#160;5.2)</span></a></td></tr>
<tr>
    <td style="vertical-align: top"><a href="tm2023139d1_ex8-1.htm"><span style="font-size: 10pt">23.3</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2023139d1_ex8-1.htm"><span style="font-size: 10pt">Consent of Skadden, Arps, Slate, Meagher&#160;&#38; Flom LLP (included in Exhibit&#160;8.1)</span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="tm2023139d1_ex99-1.htm"><span style="font-size: 10pt">99.1</span></a></td>
    <td>&#160;</td>
    <td><a href="tm2023139d1_ex99-1.htm"><span style="font-size: 10pt">Press Release Announcing Early Tender Results, dated June 23, 2020</span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="tm2023139d1_ex99-2.htm"><span style="font-size: 10pt">99.2</span></a></td>
    <td>&#160;</td>
    <td><a href="tm2023139d1_ex99-2.htm"><span style="font-size: 10pt">Press Release Announcing Pricing, dated June 23, 2020</span></a></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">104</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 4 -->
    <div style="border-bottom: Black 1pt solid; text-align: center; margin-top: 12pt; margin-bottom: 6pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td><span style="font-size: 10pt">Date: &#160;June 23, 2020</span></td>
    <td colspan="2"><span style="font-size: 10pt"><b>Healthpeak Properties,&#160;Inc.</b></span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-size: 10pt"><i>(Registrant)</i></span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="width: 51%">&#160;</td>
    <td style="width: 5%"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; width: 44%"><span style="font-size: 10pt">/s/ Peter A. Scott</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Name:</span></td>
    <td><span style="font-size: 10pt">Peter A. Scott</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Title:</span></td>
    <td><span style="font-size: 10pt">Executive Vice President and Chief Financial Officer</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1pt solid; text-align: center; margin-top: 12pt; margin-bottom: 6pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LXMdE3F3OlTEKTJEvK0uk+LWjLT+PZJvad0QQyAkJ985QgzEkha6RobjrMhhj01bK4dQYIWM5oz+I1utU/CzwIu2jpVx3foDM/IMemYUypO/d593bbFMQcphlAzlBKI4TcYw3Yjgq2dkKl2icVrVoEwJO6aWNTrFr95hr55kqHl1SQdkq8l4uzDq5TfEkYxhS3f1IL5ayPNMBIOuArFkurXfmJt11MC8xsZn2R79d/AB1gRJDA== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>tm2023139d1_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>&nbsp;</I></B></P>

<P STYLE="border-top: Black medium double; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">HEALTHPEAK PROPERTIES, INC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 8%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">TENTH SUPPLEMENTAL INDENTURE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Dated as of June 23, 2020</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">to the</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">INDENTURE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Dated as of November 19, 2012</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 8%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">2.875% SENIOR NOTES DUE 2031<BR>
</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The Bank of New York Mellon Trust Company,
N.A.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Trustee</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="border-top: Black medium double; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">TABLE OF CONTENTS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: left">ARTICLE I DEFINITIONS</TD>
    <TD STYLE="text-align: right">2</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; width: 15%">Section 1.1</TD>
    <TD STYLE="text-align: left">Definition of Terms</TD>
    <TD STYLE="text-align: right; width: 5%">2</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: left">ARTICLE II GENERAL TERMS AND CONDITIONS OF THE NOTES</TD>
    <TD STYLE="text-align: right">5</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">Section 2.1</TD>
    <TD STYLE="text-align: left">Designation and Principal Amount</TD>
    <TD STYLE="text-align: right">5</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">Section 2.2</TD>
    <TD STYLE="text-align: left">Maturity</TD>
    <TD STYLE="text-align: right">5</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">Section 2.3</TD>
    <TD STYLE="text-align: left">Further Issues</TD>
    <TD STYLE="text-align: right">5</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">Section 2.4</TD>
    <TD STYLE="text-align: left">Form of Payment</TD>
    <TD STYLE="text-align: right">5</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">Section 2.5</TD>
    <TD STYLE="text-align: left">Global Securities and Denomination of Notes</TD>
    <TD STYLE="text-align: right">5</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">Section 2.6</TD>
    <TD STYLE="text-align: left">Interest</TD>
    <TD STYLE="text-align: right">5</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">Section 2.7</TD>
    <TD STYLE="text-align: left">Redemption</TD>
    <TD STYLE="text-align: right">6</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">Section 2.8</TD>
    <TD STYLE="text-align: left">Sinking Fund</TD>
    <TD STYLE="text-align: right">6</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">Section 2.9</TD>
    <TD STYLE="text-align: left">Form of the Notes</TD>
    <TD STYLE="text-align: right">6</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">Section 2.10</TD>
    <TD STYLE="text-align: left">Place of Payment</TD>
    <TD STYLE="text-align: right">6</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center"></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: left">ARTICLE III ADDITIONAL COVENANTS APPLICABLE TO THE NOTES</TD>
    <TD STYLE="text-align: right">6</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">Section 3.1</TD>
    <TD STYLE="text-align: left">Limitations on the Incurrence of Debt</TD>
    <TD STYLE="text-align: right">6</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">Section 3.2</TD>
    <TD STYLE="text-align: left">Maintenance of Total Unencumbered Assets</TD>
    <TD STYLE="text-align: right">7</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">Section 3.3</TD>
    <TD STYLE="text-align: left">Reports by the Company.</TD>
    <TD STYLE="text-align: right">7</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">Section 3.4</TD>
    <TD STYLE="text-align: left">Additional Covenants.</TD>
    <TD STYLE="text-align: right">8</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: left">ARTICLE IV EVENTS OF DEFAULT</TD>
    <TD STYLE="text-align: right">9</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">Section 4.1</TD>
    <TD STYLE="text-align: left">Events of Default</TD>
    <TD STYLE="text-align: right">9</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: left">ARTICLE V DEFEASANCE</TD>
    <TD STYLE="text-align: right">9</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">Section 5.1</TD>
    <TD STYLE="text-align: left">Defeasance upon Deposit of Moneys or U.S. Government Obligations.</TD>
    <TD STYLE="text-align: right">9</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: left">ARTICLE VI ORIGINAL ISSUANCE OF NOTES</TD>
    <TD STYLE="text-align: right">9</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">Section 6.1</TD>
    <TD STYLE="text-align: left">Original Issue of Notes</TD>
    <TD STYLE="text-align: right">9</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">Section 6.2</TD>
    <TD STYLE="text-align: left">Appointment of Agents. The Trustee shall initially be the Registrar and Paying Agent for the Notes.</TD>
    <TD STYLE="text-align: right">9</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: left">ARTICLE VII MISCELLANEOUS</TD>
    <TD STYLE="text-align: right">10</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">Section 7.1</TD>
    <TD STYLE="text-align: left">Applicability of Supplemental Indenture</TD>
    <TD STYLE="text-align: right">10</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">Section 7.2</TD>
    <TD STYLE="text-align: left">Ratification of Indenture</TD>
    <TD STYLE="text-align: right">10</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">Section 7.3</TD>
    <TD STYLE="text-align: left">Trustee Not Responsible for Recitals</TD>
    <TD STYLE="text-align: right">10</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">Section 7.4</TD>
    <TD STYLE="text-align: left">Governing Law</TD>
    <TD STYLE="text-align: right">10</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">Section 7.5</TD>
    <TD STYLE="text-align: left">Separability</TD>
    <TD STYLE="text-align: right">10</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center">Section 7.6</TD>
    <TD STYLE="text-align: left">Counterparts Originals</TD>
    <TD STYLE="text-align: right">10</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">TENTH SUPPLEMENTAL
INDENTURE, dated as of June 23, 2020 (this &ldquo;Supplemental Indenture&rdquo;), by and between <B>HEALTHPEAK PROPERTIES, INC.
</B>(formerly known as HCP, Inc.), a corporation duly organized and existing under the laws of the State of Maryland (the &ldquo;Company&rdquo;),
and <B>The Bank of New York Mellon Trust Company, N.A.</B>, as trustee, a national banking association organized and existing under
the laws of the United States of America, as Trustee under the Indenture (as hereinafter defined) (the &ldquo;Trustee&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">RECITALS OF THE COMPANY</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and the Trustee are parties to that certain Indenture, dated as of November 19, 2012 (the &ldquo;Base Indenture&rdquo;,
and as supplemented by this Supplemental Indenture, the &ldquo;Indenture&rdquo;), to provide for the issuance of Securities to
be issued in one or more series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
Section 14.01 of the Base Indenture, the Company and the Trustee are authorized to enter into one or more indentures supplemental
to the Base Indenture, without the consent of the Holders of Securities, in order to establish the forms and terms of Securities
of any series pursuant to Section 3.01 of the Base Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company desires to provide for the establishment of a new series of Securities under the Base Indenture to be known as the &ldquo;2.875%
Senior Notes due 2031&rdquo; (the &ldquo;Notes&rdquo;), the form and substance and the terms, provisions and conditions thereof
to be set forth as provided in the Base Indenture and this Supplemental Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Concurrent
with the execution hereof, the Company has delivered to the Trustee an Officer&rsquo;s Certificate and caused its counsel to deliver
to the Trustee an Opinion of Counsel, each pursuant to Section 16.01 of the Base Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">E.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company has done all things necessary to make this Supplemental Indenture a valid agreement of the Company, in accordance with
its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW THEREFORE, in consideration
of the premises and the purchase and acceptance of the Notes by the Holders thereof, and for the purpose of setting forth, as provided
in the Base Indenture, the forms and terms of the Notes, the Company covenants and agrees, with the Trustee, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
I</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><U>DEFINITIONS</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 1.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Definition of Terms</U>. Unless the context otherwise requires:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>each term defined in the Base Indenture has the same meaning when used in this Supplemental Indenture;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>unless otherwise defined in the Indenture or the context otherwise requires, all terms used herein without definition which
are defined in the Trust Indenture Act, either directly or by reference therein, have the meanings assigned to them therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the singular includes the plural and vice versa;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>headings are for convenience of reference only and do not affect interpretation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the words &ldquo;herein&rdquo;, &ldquo;hereof&rdquo; and &ldquo;hereunder&rdquo; and other words of similar import refer
to the Indenture as a whole and not to any particular Article, Section or other subdivision;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a reference to a Section or Article is to a Section or Article of this Supplemental Indenture unless otherwise indicated;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the following terms have the meanings given to them in this Section 1.1(g):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<I>Capitalized
Lease</I>&rdquo; means at any time any lease of Property which, in accordance with GAAP, would at such time be required to be capitalized
on a balance sheet of the lessee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<I>Consolidated
EBITDA</I>&rdquo; means, for any period of time, the net income (loss) of the Company and its Subsidiaries, determined on a consolidated
basis in accordance with GAAP for such period, before deductions for (without duplication):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(1)</TD><TD>Interest Expense;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(2)</TD><TD>taxes;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(3)</TD><TD>depreciation, amortization, and all other non-cash items, as determined reasonably and in good faith by the Company, deducted
in arriving at net income (loss);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(4)</TD><TD>extraordinary items, including impairment charges;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(5)</TD><TD>non-recurring items or other unusual items, as determined reasonably and in good faith by the Company (including, without limitation,
all prepayment penalties and all costs or fees incurred in connection with any debt financing or amendment thereto, acquisition,
disposition, recapitalization or similar transaction (regardless of whether such transaction is completed));</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(6)</TD><TD>noncontrolling interests;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(7)</TD><TD>income or expense attributable to transactions involving derivative instruments that do not qualify for hedge accounting in
accordance with GAAP; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(8)</TD><TD>gains or losses on dispositions of depreciable real estate investments, property valuation losses and impairment charges.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of calculating
Consolidated EBITDA, all amounts shall be as determined reasonably and in good faith by the Company, and in accordance with GAAP
except to the extent that GAAP is not applicable with respect to the determination of all non-cash and non-recurring items.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<I>Consolidated
Financial Statements</I>&rdquo; means, with respect to any Person, collectively, the consolidated financial statements and notes
to those financial statements, of that Person and its Subsidiaries prepared in accordance with GAAP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<I>Incur</I>&rdquo;
means, with respect to any Debt or other obligation of any Person, to create, assume, guarantee or otherwise become liable in respect
of such Debt or other obligation, and &ldquo;Incurrence&rdquo; and &ldquo;Incurred&rdquo; have the meanings correlative to the
foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<I>Interest
Expense</I>&rdquo; means, for any period of time, the aggregate amount of interest recorded in accordance with GAAP for such period
by the Company and its Subsidiaries, but <I>excluding </I>(i) interest reserves funded from the proceeds of any loan, (ii) prepayment
penalties, (iii) amortization of deferred financing costs, and (iv) non-cash swap ineffectiveness charges, in all cases as reflected
in the applicable Consolidated Financial Statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<I>Latest Completed
Quarter</I>&rdquo; means, as of any date, the then most recently ended fiscal quarter of the Company for which Consolidated Financial
Statements of the Company have been completed, it being understood that at any time when the Company is subject to the informational
requirements of the Exchange Act, and in accordance therewith files annual and quarterly reports with the SEC, the term &ldquo;<I>Latest
Completed Quarter</I>&rdquo; shall be deemed to refer to the fiscal quarter covered by the Company&rsquo;s most recently filed
Quarterly Report on Form 10-Q, or, in the case of the last fiscal quarter of the year, the Company&rsquo;s Annual Report on Form
10-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<I>Property</I>&rdquo;
means any interest in any kind of property or asset, whether real, personal or mixed, tangible or intangible.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<I>Real Estate
Assets</I>&rdquo; means, as of any date, the real estate assets of such Person and its Subsidiaries on such date, on a consolidated
basis determined in accordance with GAAP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<I>Secured Debt</I>&rdquo;
means, as of any date, that portion of the aggregate principal amount of all outstanding Debt of the Company and its Subsidiaries
as of that date that is secured by a Lien on properties or other assets of the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<I>Total Assets</I>&rdquo;
means, as of any date, the consolidated total assets of the Company and its Subsidiaries, as such amount would appear on a consolidated
balance sheet of the Company prepared as of such date in accordance with GAAP. &ldquo;Total Assets&rdquo; shall include Undepreciated
Real Estate Assets and all other assets but shall exclude goodwill, and shall include the proceeds of the Debt or Secured Debt
to be Incurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<I>Total Unencumbered
Assets</I>&rdquo; means, as of any date, Undepreciated Real Estate Assets of the Company and its Subsidiaries that are not subject
to any Lien which secures Debt of any of the Company and its Subsidiaries plus, without duplication, loan loss reserves relating
thereto, accumulated depreciation thereon, plus all other assets of the Company and its Subsidiaries as all such amounts would
appear on a consolidated balance sheet of the Company prepared as of such date in accordance with GAAP plus the proceeds of the
Debt or Secured Debt to be Incurred; provided, however, that &ldquo;Total Unencumbered Assets&rdquo; does not include net real
estate investments under unconsolidated joint ventures of the Company and its Subsidiaries and does not include goodwill.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<I>Undepreciated
Real Estate Assets</I>&rdquo; means, as of any date, the amount of real estate assets valued at original cost plus capital improvements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<I>Unsecured
Debt</I>&rdquo; means, as of any date, that portion of the aggregate principal amount of all outstanding Debt of the Company and
its Subsidiaries as of that date that is not Secured Debt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
II</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><U>GENERAL TERMS AND CONDITIONS OF THE NOTES</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 2.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Designation and Principal Amount</U>. There is hereby authorized and established a new series of Securities under the
Base Indenture designated as the &ldquo;2.875% Senior Notes due 2031,&rdquo; which is not limited in aggregate principal amount.
The initial aggregate principal amount of the Notes to be issued on June 23, 2020 under this Supplemental Indenture shall be $600,000,000
(except for Notes authenticated and delivered upon transfer of, or in exchange for, or in lieu of, other Notes pursuant to Sections
3.04, 3.06, 3.07, 4.06 or 14.05 of the Base Indenture). Any additional amounts of Notes to be issued shall be set forth in an Officer&rsquo;s
Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 2.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Maturity</U>. The Stated Maturity of principal for the Notes shall be January 15, 2031.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 2.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Further Issues</U>. The Company may from time to time, without the consent of the Holders of the Notes, issue additional
Notes, but only if such additional Notes are issued as part of a &ldquo;qualified reopening&rdquo; for U.S. federal income tax
purposes. Any such additional Notes shall have the same ranking, interest rate, maturity date and other terms as the outstanding
Notes (other than the offering price, the date of issuance and, under certain circumstances, the date from which interest thereon
shall begin to accrue and the first interest payment date). Any such additional Notes, together with the Notes herein provided
for, shall constitute a single series of Securities under the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 2.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Form of Payment</U>. The Notes shall be denominated in, and principal of, premium, if any, and interest on the Notes
shall be payable in U.S. dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 2.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Global Securities and Denomination of Notes</U>. Upon the original issuance, the Notes shall be represented by one or
more Global Securities without coupons. The Company shall issue the Notes in minimum denominations of $2,000 and in integral multiples
of $1,000 in excess thereof and shall deposit the Global Securities with the Trustee as custodian for DTC (which shall act as the
Depositary for the Notes) in New York, New York, and register the Global Securities in the name of DTC or its nominee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 2.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Interest</U>. The Notes shall bear interest (computed on the basis of a 360-day year consisting of twelve 30-day months)
from June 23, 2020 at the rate of 2.875% per annum payable in cash semiannually in arrears; interest payable on each Interest Payment
Date shall include interest accrued from June 23, 2020, or from the most recent Interest Payment Date to which interest has been
paid or duly provided for; the Interest Payment Dates on which such interest shall be payable are January 15 and July 15, commencing
on January 15, 2021; and interest shall be payable on any Interest Payment Date to the Person or Persons in whose name the Notes
are registered at the close of business on the fifteenth calendar day preceding the relevant Interest Payment Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 2.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Redemption</U>. The Notes are subject to redemption at the option of the Company as set forth in the form of Note attached
hereto as <U>Exhibit A</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 2.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Sinking Fund</U>. The Notes are not subject to any sinking fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 2.9<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Form of the Notes</U>. The Notes shall have such other terms and provisions as are set forth in the form of certificate
evidencing the Notes attached hereto as <U>Exhibit A</U>, all of which terms and provisions are incorporated by reference in and
made a part of Article II to this Supplemental Indenture as if set forth in full herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 2.10<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Place of Payment, Transfer and Exchange</U>. Principal of, premium, if any, and interest on the Notes shall be payable,
Notes may be presented for registration of transfer or exchange, and notices and demands to or upon the Company in respect of the
Notes may be made, at the Corporate Trust Office of the Trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
III</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: none"><U>ADDITIONAL COVENANTS APPLICABLE TO THE NOTES</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 3.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Limitations on the Incurrence of Debt</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company shall not, and shall not permit any of its Subsidiaries to, Incur any Debt if, immediately after giving effect
to the Incurrence of such additional Debt and any other Debt Incurred since the end of the Latest Completed Quarter and the application
of the net proceeds therefrom, the aggregate principal amount of all outstanding Debt would exceed 60% of the sum of (without duplication)
(i) Total Assets as of the end of the Latest Completed Quarter and (ii) the purchase price of any Real Estate Assets or mortgages
receivable acquired or to be acquired in exchange for proceeds of any securities offering, and the amount of any securities offering
proceeds received (to the extent such proceeds were not used to acquire Real Estate Assets or mortgages receivable or to reduce
Debt), since the end of the Latest Completed Quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company shall not, and shall not permit any of its Subsidiaries to, Incur any Secured Debt if, immediately after giving
effect to the Incurrence of such additional Secured Debt and any other Secured Debt Incurred since the end of the Latest Completed
Quarter and the application of the net proceeds therefrom, the aggregate principal amount of all outstanding Secured Debt would
exceed 40% of the sum of (without duplication) (i) Total Assets as of the end of the Latest Completed Quarter and (ii) the purchase
price of any Real Estate Assets or mortgages receivable acquired or to be acquired in exchange for proceeds of any securities offering,
and the amount of any securities offering proceeds received (to the extent such proceeds were not used to acquire Real Estate Assets
or mortgages receivable or to reduce Debt), since the end of the Latest Completed Quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company shall not, and shall not permit any of its Subsidiaries to, Incur any Debt if, immediately after giving effect
to the Incurrence of such additional Debt and any other Debt Incurred since the end of the Latest Completed Quarter and the application
of the net proceeds therefrom, the ratio of Consolidated EBITDA to Interest Expense for the four consecutive fiscal quarters ending
with the Latest Completed Quarter would be less than 1.50 to 1.00 on a pro forma basis and calculated on the assumption (without
duplication) that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
additional Debt and any other Debt Incurred by the Company or any of its Subsidiaries since the first day of such four-quarter
period to the date of determination, which was outstanding at the date of determination, had been Incurred at the beginning of
that period and continued to be outstanding throughout that period, and the application of the net proceeds of such Debt, including
to refinance other Debt, had occurred at the beginning of such period; provided that in determining the amount of Debt so Incurred,
the amount of Debt under any revolving credit facility shall be computed based upon the average daily balance of such Debt during
such period;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
repayment or retirement of any other Debt repaid or retired by the Company or any of its Subsidiaries since the first day of such
four-quarter period to the date of determination had occurred at the beginning of that period; provided that in determining the
amount of Debt so repaid or retired, the amount of Debt under any revolving credit facility shall be computed based upon the average
daily balance of such Debt during such period; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in
the case of any acquisition or disposition of any asset or group of assets (including, without limitation, by merger, or stock
or asset purchase or sale) or the placement of any assets in service or removal of any assets from service by the Company or any
of its Subsidiaries since the first day of such four-quarter period to the date of determination, the acquisition, disposition,
placement in service or removal from service and any related repayment or refinancing of Debt had occurred as of the first day
of such period, with the appropriate adjustments to Consolidated EBITDA and Interest Expense with respect to the acquisition, disposition,
placement in service or removal from service being included in that pro forma calculation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 3.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Maintenance
of Total Unencumbered Assets</U>. The Company and its Subsidiaries shall maintain at all times Total Unencumbered Assets of
not less than 150% of the aggregate principal amount of all outstanding Unsecured Debt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 3.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Reports by the Company</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For so long as the
Notes are outstanding, the Company shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>file with or deliver to the Trustee, within 15&nbsp;days after the Company is required to file the same with the Securities
and Exchange Commission (the &ldquo;SEC&rdquo;), copies of the annual and quarterly reports and the information, documents and
other reports (or copies of such portions of any of the foregoing as the SEC may from time to time by rules and regulations prescribe)
that the Company may be required to file with the SEC pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the Exchange Act; or,
if the Company is not required to file information, documents or reports with the SEC pursuant to either Section 13 or Section
15(d) of the Exchange Act, then the Company will file with or deliver to the Trustee and the SEC, in accordance with any other
rules and regulations that may be prescribed from time to time by the SEC, such annual and quarterly reports and supplementary
and periodic information, documents and reports that may be required pursuant to Section&nbsp;13 of the Exchange Act, in respect
of a security listed and registered on a national securities exchange, as may be prescribed from time to time by the SEC in such
rules and regulations; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>if at any time the Company is not subject to Section&nbsp;13 or 15(d) of the Exchange Act and the Company is not providing
annual and quarterly reports and supplementary and periodic information, documents and reports to the SEC and the Trustee pursuant
to Section 3.3(a) of this Supplemental Indenture, the Company will, at its option, either (i)&nbsp;post on a publicly available
website or (ii)&nbsp;post on IntraLinks or any comparable password protected online data system requiring user identification and
a confidentiality acknowledgement (a &ldquo;Confidential Datasite&rdquo;), within 15 days of the filing date that would be applicable
to a non-accelerated filer at that time pursuant to applicable SEC rules and regulations, the quarterly and audited annual financial
statements and accompanying disclosure described in Item 303 of Regulation&nbsp;S-K (&ldquo;management&rsquo;s discussion and analysis
of financial condition and results of operations&rdquo;) that would be required to be contained in annual reports on Form&nbsp;10-K
and quarterly reports on Form&nbsp;10-Q, respectively, required to be filed with the SEC if the Company were subject to Section
13(a) or 15(d) of the Exchange Act. If the Company elects to furnish such reports via a Confidential Datasite, access to the Confidential
Datasite will be provided promptly upon request to Holders and beneficial owners of, and bona fide potential investors in, the
Notes as well as securities analysts and market makers and no such request for access to the Confidential Datasite will be unreasonably
denied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any such report, information
or document that the Company files with or furnishes to the SEC through the SEC&rsquo;s Electronic Data Gathering Analysis and
Retrieval system (or any successor thereto) (&ldquo;EDGAR&rdquo;) shall be deemed filed with the Trustee for purposes of Section
3.3(a) and (b) of this Supplemental Indenture at the time of such filing or furnishing through EDGAR. Delivery of such reports,
information and documents to the Trustee is for informational purposes only, and the Trustee&rsquo;s receipt of such will not constitute
actual or constructive notice of any information contained therein or determinable from information contained therein, including
the Company&rsquo;s compliance with any of the Company&rsquo;s covenants of the Indenture relating to the Notes (as to which the
Trustee is entitled to rely exclusively on an Officer&rsquo;s Certificate).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 3.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Additional Covenants.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With respect to the
Notes, the covenants set forth in Sections 3.1 and 3.2 of this Supplemental Indenture supplement those covenants set forth in Article
VI of the Base Indenture and the covenant set forth in Section 3.3 of this Supplemental Indenture replaces in its entirety the
covenant set forth in Section 10.02 of the Base Indenture and with respect to the Notes, all references to Section 10.02 of the
Base Indenture contained in the Base Indenture and this Supplemental Indenture shall be deemed to refer to Section 3.3 of this
Supplemental Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
IV</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><U>EVENTS OF DEFAULT</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 4.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Events of Default</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The term &ldquo;Event
of Default&rdquo; as used in the Indenture with respect to the Notes shall include the following described event in addition to
those set forth in Section 7.01 of the Base Indenture:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(i) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
any event of default as defined in any mortgage, indenture or instrument under which there may be issued, or by which there may
be secured or evidenced, any Debt (including obligations under Capitalized Leases) of the Company (including an Event of Default
with respect to any Outstanding Securities of any series other than the Notes) in an aggregate amount in excess of $50,000,000,
whether such Debt now exists or shall hereafter be created, shall happen and shall result in such Debt becoming or being declared
due and payable prior to the date on which it would otherwise become due and payable, and such acceleration shall not have been
rescinded or annulled within ten days after there shall have been given, by registered or certified mail, to the Company by the
Trustee or to the Company and the Trustee by the Holders of at least 25% in aggregate principal amount of the Outstanding Notes,
a written notice specifying such event of default and requiring the Company to cause such acceleration to be rescinded or annulled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
V</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><U>DEFEASANCE</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 5.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Defeasance upon Deposit of Moneys or U.S. Government Obligations</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At the Company&rsquo;s
option, either (a) the Company shall be deemed to have been Discharged from its obligations with respect to the Notes on the first
day after the applicable conditions set forth in Section 12.03 of the Base Indenture have been satisfied or (b) the Company shall
cease to be under any obligation to comply with any term, provision or condition set forth in Section 6.08 or 10.02 of the Base
Indenture and Sections 3.1, 3.2 and 4.1 of this Supplemental Indenture with respect to the Notes at any time after the applicable
conditions set forth in Section 12.03 of the Base Indenture have been satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
VI<U><BR>
<BR>
ORIGINAL ISSUANCE OF NOTES</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 6.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Original Issue of Notes</U>. The Notes may, upon execution of this Supplemental Indenture, be executed by the Company
and delivered to the Trustee for authentication, and the Trustee shall, upon receipt of a Company Order, authenticate and deliver
such series of Notes as in such Company Order provided.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 6.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Appointment of Agents</U>. The Trustee shall initially be the Registrar and Paying Agent for the Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
VII</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><U>MISCELLANEOUS</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 7.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Applicability of Supplemental Indenture</U>. Each and every term and condition contained in this Supplemental Indenture
shall apply to the Notes issued on the date hereof or hereafter, but not to any other series of Securities issued or to be issued
under the Indenture. Except as specifically amended and supplemented by, or to the extent inconsistent with, this Supplemental
Indenture, the Indenture shall remain in full force and effect and is hereby ratified and confirmed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 7.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Ratification of Indenture</U>. The Base Indenture, as supplemented by this Supplemental Indenture, is in all respects
ratified and confirmed, and this Supplemental Indenture shall be deemed part of the Base Indenture in the manner and to the extent
herein and therein provided; provided that the provisions of this Supplemental Indenture apply solely with respect to these Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 7.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Trustee Not Responsible for Recitals</U>. The recitals herein contained are made by the Company and not by the Trustee,
and the Trustee assumes no responsibility for the correctness thereof. The Trustee makes no representation as to the validity or
sufficiency of this Supplemental Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 7.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Governing Law</U>. This Supplemental Indenture and each Note shall be deemed to be contracts made under the law of the
State of New York, and for all purposes shall be governed by and construed in accordance with the law of said State.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 7.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Separability</U>. In case any provision in this Supplemental Indenture or in any of the Notes of this series shall be
invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be
affected or impaired thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Section 7.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Counterparts Originals</U>. This Supplemental Indenture may be executed in any number of counterparts, each of which
so executed shall be deemed to be an original, but all such counterparts shall together constitute but one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the parties hereto have caused this Supplemental Indenture to be duly executed by their respective officers hereunto duly authorized,
all as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">HEALTHPEAK PROPERTIES, INC.,
    as Issuer</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%"><FONT STYLE="font-size: 10pt">By:&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">/s/ Peter A. Scott</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in"><FONT STYLE="font-size: 10pt">Peter A. Scott</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in"><FONT STYLE="font-size: 10pt">Executive Vice President and Chief Financial Officer</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 225pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature Page to Supplemental Indenture]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 225pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 225pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 225pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
    BANK OF NEW YORK MELLON<BR> TRUST COMPANY, N.A., as Trustee</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Kenneth Helbig</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kenneth Helbig</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vice President</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature Page to Supplemental Indenture]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">EXHIBIT A</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">No. R-[&#9679;]</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 48%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CUSIP NO. 42250P AB9</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ISIN NO. US42250PAB94</P></TD>
    <TD STYLE="vertical-align: bottom; width: 7%; font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 45%; font-size: 10pt; text-align: right">PRINCIPAL AMOUNT</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">$[ ]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">HEALTHPEAK PROPERTIES, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">2.875% SENIOR NOTES DUE 2031</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS SECURITY IS A
GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITARY OR
A NOMINEE OF THE DEPOSITARY, WHICH SHALL BE TREATED BY THE COMPANY, THE TRUSTEE AND ANY AGENT THEREOF AS OWNER AND HOLDER OF THIS
SECURITY FOR ALL PURPOSES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">UNLESS THIS CERTIFICATE
IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (&ldquo;DTC&rdquo;) TO THE
COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF
CEDE &amp; CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT HEREON IS MADE TO
CEDE &amp; CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE
HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL SINCE THE REGISTERED OWNER HEREOF, CEDE &amp; CO., HAS AN INTEREST
HEREIN.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">TRANSFERS OF THIS GLOBAL
SECURITY SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY, OR BY A NOMINEE
OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY, OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR
DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">HEALTHPEAK PROPERTIES,
INC. (formerly known as HCP, Inc.), a Maryland corporation (the &ldquo;Company&rdquo;, which term shall include any successor under
the Indenture hereinafter referred to), for value received, hereby promises to pay to CEDE&nbsp;&amp; CO., or registered assigns,
the principal sum of [ ] Million Dollars ($[ ]) on January 15, 2031, and to pay interest thereon from June 23, 2020 or from the
most recent interest payment date on which interest has been paid or duly provided for, semi-annually in arrears on January 15
and July 15 (each, an &ldquo;Interest Payment Date&rdquo;) of each year (or if such date is not a Business Day, on the next Business
Day thereafter; no interest will accrue on such payment for the period from and after such Interest Payment Date to the date of
such payment on the next succeeding Business Day), commencing January 15, 2021, at the rate of 2.875% per annum, until the entire
principal amount hereof is paid or duly provided for. The interest so payable, and punctually paid or duly provided for, on any
Interest Payment Date will, as provided in the Indenture, be paid to the Holder in whose name this Note (or one or more predecessor
Notes) is registered at the close of business on the Record Date for such interest, which shall be the date that is 15 calendar
days prior to such Interest Payment Date, whether or not a Business Day. Any such interest not so punctually paid or duly provided
for, on any Interest Payment Date shall forthwith cease to be payable to the Holder on such Record Date, and may&nbsp;either be
paid to the Holder in whose name this Note (or one or more predecessor Notes) is registered at the close of business on a Special
Record Date for the payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders of
Notes of this series&nbsp;not less than 10 calendar days prior to such Special Record Date, or may&nbsp;be paid at any time in
any other lawful manner not inconsistent with the requirements of any securities exchange on which the Notes may&nbsp;be listed,
and upon such notice as may&nbsp;be required by such exchange, all as more fully provided in the Indenture. Interest will be computed
on the basis of a 360-day year of twelve 30-day months. Payments of principal, premium, if any, and interest in respect of this
Note will be made by the Company in immediately available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Payment of the principal
of and interest on this Note shall be payable at the Corporate Trust Office of The Bank of New York Mellon Trust Company, N.A.,
located at 101 Barclay Street, Floor 8 W, New York, New York 10286, or at such other office or agency of the Company maintained
for that purpose in The City of New York, in such coin or currency of the United States of America as at the time of payment is
legal tender for payment of public and private debts; provided, however, that, at the option of the Company, interest may&nbsp;be
paid by check mailed to the address of the Person entitled thereto as such address shall appear on the Register or by wire transfer
to an account designated by the Holder; and, provided, further, that so long as this Note is registered in the name of DTC or its
nominee, principal and interest payments will be paid to DTC or its nominee, as the Holder, by wire transfer in same-day funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is hereby
made to the further provisions of this Note set forth on the reverse hereof, which further provisions shall for all purposes have
the same effect as if set forth at this place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the certificate
of authentication hereon has been executed by the Trustee by manual signature of one of its authorized signatories, this Note shall
not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the Company has caused
this instrument to be duly executed this 23rd day of June, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">Healthpeak Properties, Inc.,</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">a Maryland corporation</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 4%; text-align: justify">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 46%; text-align: justify">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Name:&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: justify">Peter A. Scott</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="text-align: left">Executive Vice President and Chief Financial Officer</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Attest:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; text-align: justify">By:</TD>
    <TD STYLE="width: 46%; border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Name:&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: justify">Troy E. McHenry</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="text-align: left">Executive Vice President, Chief Legal Officer and Corporate Secretary</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">TRUSTEE&rsquo;S CERTIFICATE OF AUTHENTICATION:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This is one of the
Notes of the series designated herein referred to in the within-mentioned Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">The Bank of New York Mellon Trust Company, N.A., as Trustee</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: justify">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 48%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Authorized Signatory</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">Dated: June 23, 2020</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Note is one of
a duly authorized issue of securities designated as the &ldquo;2.875% Senior Notes due 2031&rdquo; (herein called the &ldquo;Notes&rdquo;)
of Healthpeak Properties, Inc. (formerly known as HCP, Inc.), a Maryland Corporation, and any of its successors and assigns (the
 &ldquo;Company&rdquo;), issued as a series&nbsp;of securities under an indenture, dated as of November 19, 2012 (the &ldquo;Base
Indenture&rdquo;), as supplemented by the Tenth Supplemental Indenture, dated as of June 23, 2020 (the &ldquo;Supplemental Indenture&rdquo;
and together with the Base Indenture, the &ldquo;Indenture&rdquo;), each between the Company and The Bank of New York Mellon Trust
Company, N.A. (the &ldquo;Trustee,&rdquo; which term includes any successor trustee under the Indenture with respect to the Notes).
Reference is hereby made for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the
Company, the Trustee and the Holders of the Notes and of the terms upon which the Notes are, and are to be, authenticated and delivered.
This Note is one of a duly authorized series&nbsp;of securities of the Company originally limited (subject to exceptions provided
in the Indenture) in aggregate principal amount to $600,000,000; however, from time to time, without giving notice or seeking consent
of the Holders of the Notes, the Company may issue additional Notes of this series&nbsp;having the same ranking, interest rate
and maturity and other terms as this Note <FONT STYLE="background-color: white">(other than the offering price, the date of issuance
and, under certain circumstances, the date from which interest thereon shall begin to accrue and the first interest payment date)</FONT>.
All terms used in this Note which are defined in the Indenture shall have the meanings assigned to them in the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If an Event of Default
with respect to the Notes shall occur and be continuing, the principal of the Notes may be declared due and payable in the manner
and with the effect provided in the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Notes are not subject
to any sinking fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prior
to the Par Call Date (as defined below), the Notes may be redeemed, at any time in whole or from time to time in part at the option
of the Company at a Redemption Price equal to the greater of: (1) 100% of the principal amount of the Notes to be redeemed on that
Redemption Date, or (2) the sum of the present values of the remaining scheduled payments of principal and interest </FONT>on the
Notes to be redeemed <FONT STYLE="font-family: Times New Roman, Times, Serif">(exclusive of interest accrued to, but excluding,
the Redemption Date) </FONT>that would be due if the Notes matured on the Par Call Date, <FONT STYLE="font-family: Times New Roman, Times, Serif">discounted
to the Redemption Date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate
(as defined below) plus </FONT>35 <FONT STYLE="font-family: Times New Roman, Times, Serif">basis points, plus, in either case,
accrued and unpaid interest on the Notes being redeemed to, but excluding, the Redemption Date; provided, however, that if the
Company redeems the Notes on and after the Par Call Date, the Company may at its option redeem the Notes at any time in whole or
from time to time in part at a Redemption Price that will equal 100% of the principal amount of the Notes to be redeemed plus accrued
and unpaid interest thereon to, but excluding, the Redemption Date; provided, further, that installments of interest on the Notes
that are due and payable on any Interest Payment Date falling on or prior to a Redemption Date for the Notes shall be payable on
such Interest Payment Dates to the Holder of the Note at the close of business on the applicable Record Dates. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<I>Par Call Date</I>&rdquo; means
the date that is October 15, 2030.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Treasury
Rate</I></FONT>&rdquo; means, the arithmetic mean (rounded to the nearest one-hundredth of one percent) of the yields displayed
for each of the five most recent days published in the most recent Statistical Release under the caption &ldquo;Treasury constant
maturities&rdquo; for the maturity (rounded to the nearest month) corresponding to the remaining life to maturity of the Notes
(assuming the Notes mature on the Par Call Date) as of the Redemption Date. If no maturity exactly corresponds to such remaining
life to maturity, yields for the two published maturities most closely corresponding to such remaining life to maturity shall be
calculated pursuant to the immediately preceding sentence and the Treasury Rate shall be interpolated or extrapolated from such
yields on a straight-line basis, rounding in each of such relevant periods to the nearest month. The Treasury Rate will be calculated
on the third Business Day preceding the date the applicable notice of redemption is given. For the purpose of calculating the Treasury
Rate, the most recent Statistical Release published prior to the date of calculation of the Treasury Rate shall be used.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<I>Statistical Release</I>&rdquo;
means that statistical release designated &ldquo;H.15&rdquo; or any successor publication published daily by the Board of Governors
of the Federal Reserve System and which establishes yields on actively traded U.S. Treasury securities adjusted to constant maturity,
or, if such release (or any successor publication) is no longer published at the time of any calculation under the Indenture, then
such other reasonably comparable index the Company designates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company may redeem the Notes in increments of $</FONT>1,000 so long as, in the case of any Note redeemed in part, the unredeemed
principal amount thereof is $2,000 or an integral multiple of $1,000 in excess thereof<FONT STYLE="font-family: Times New Roman, Times, Serif">.
If the Company redeems less than all of the Notes, the Notes to be redeemed will be selected </FONT>in accordance with the procedures
of DTC<FONT STYLE="font-family: Times New Roman, Times, Serif">. The Company will cause notices of redemption to be delivered at
least 15 but not more than 60 days before the Redemption Date to each Holder of Notes to be redeemed at its registered address
or by delivery to DTC for posting through its Legal Notice Service (&ldquo;LENS&rdquo;) or a successor system thereof. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If this Note is to
be redeemed in part only, the notice of redemption that relates to this Note will state the portion of the principal amount thereof
to be redeemed. The Company will issue a Note in principal amount equal to the unredeemed portion of this Note in the name of the
Holder hereof upon cancellation of the original Note. Any Notes called for redemption will become due on the Redemption Date. On
or after the Redemption Date, interest will cease to accrue on the Notes or portions of them called for redemption. <FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">A
notice of redemption may be conditional.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As provided in and
subject to the provisions of the Indenture, the Holder of this Note shall not have any right to institute any action, suit or proceeding
at law or in equity for the execution of any trust under the Indenture or for the appointment of a receiver or for any other remedy
under the Indenture, in each case with respect to an Event of Default with respect to the Notes, unless such Holder previously
shall have given to the Trustee written notice of one or more of the Events of Default with respect to the Notes, and unless also
the Holders of 25% or more in principal amount of the Notes then Outstanding shall have requested the Trustee in writing to take
action in respect of the matter complained of, and unless also there shall have been offered to the Trustee security and indemnity
reasonably satisfactory to it against the costs, expenses and liabilities to be incurred therein or thereby, and the Trustee, for
60 days after receipt of such notification, request and offer of indemnity, shall have neglected or refused to institute any such
action, suit or proceeding; provided, however, that the foregoing shall not affect or impair the obligation of the Company, which
is absolute and unconditional, to pay the principal of, premium, if any, and interest on this Note to the Holder at the due date
herein stated, or affect or impair the right, which is also absolute and unconditional, of the Holder to institute suit to enforce
the payment thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture permits,
with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company
and the rights of the Holders of the Notes under the Indenture at any time by the Company and the Trustee with the consent of the
Holders of not less than a majority in aggregate principal amount of the Outstanding Notes. The Indenture also contains provisions
permitting the Holders of not less than a majority in principal amount of the Notes at the time Outstanding, on behalf of the Holders
of all Notes, to waive compliance by the Company with certain provisions of the Indenture. Furthermore, provisions in the Indenture
permit the Holders of not less than a majority of the aggregate principal amount of the Outstanding Notes to waive, in certain
circumstances, on behalf of all Holders of the Notes, certain past defaults under the Indenture and their consequences. Any such
consent or waiver by the Holder of this Note shall be conclusive and binding upon such Holder and upon all future Holders of this
Note and of any Note issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation
of such consent or waiver is made upon this Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No reference herein
to the Indenture and no provision of this Note or of the Indenture shall alter or impair the obligation of the Company, which is
absolute and unconditional, to pay the principal of, premium, if any and interest on, this Note at the times, places and rate,
and in the coin or currency, herein and in the Indenture prescribed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As provided in the
Indenture and subject to certain limitations set forth therein, the transfer of this Note may&nbsp;be registered on the Register
upon surrender of this Note for registration of transfer at the office or agency of the Company maintained for the purpose in any
place where the principal of, premium, if any and interest on this Note are payable, duly endorsed by or accompanied by a written
instrument of transfer in form&nbsp;satisfactory to the Company, the Trustee and the Registrar duly executed by the Holder hereof
or by his attorney duly authorized in writing, and thereupon one or more new Notes of this series, of authorized denominations
and for the same aggregate principal amount, will be issued to the designated transferee or transferees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Note may be transferred,
in whole but not in part, only to a nominee of DTC, or by a nominee of DTC to DTC, or to a successor to DTC for such Global Security
selected or approved by the Company or to a nominee of such successor to DTC. If at any time DTC notifies the Company that it is
unwilling or unable to continue as Depositary for the Notes or if at any time DTC ceases to be a clearing agency registered under
the Exchange Act and any other applicable statute and regulation, if so required by applicable law or regulation, the Company shall
appoint a successor Depositary with respect to the Notes. If (a) a successor Depositary for the Notes is not appointed by the Company
within 90 days after the Company receives such notice or becomes aware of such ineligibility, as the case may be, (b) an Event
of Default has occurred and is continuing, or (c) the Company, in its sole discretion, determines at any time that all Notes (but
not less than all) of this series&nbsp;shall no longer be represented by such Global Note or Notes and executes and delivers to
the Trustee an Officer&rsquo;s Certificate stating that the Notes shall be so exchangeable, then the Company shall execute, and
the Trustee shall authenticate and deliver, definitive Notes of like series, rank, tenor and terms in definitive form in an aggregate
principal amount equal to the principal amount of such Note or Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Notes are issuable
only in registered form without coupons and may&nbsp;be sold in denominations of $2,000 and integral multiples of $1,000 in excess
thereof. As provided in the Indenture and subject to certain limitations therein set forth, the Notes of this series&nbsp;are exchangeable
for a like aggregate principal amount of Notes of this series in authorized denominations as requested by the Holders surrendering
the same. No service charge shall be made for any such registration of transfer or exchange, but the Company or Trustee may in
certain circumstances require payment of a sum sufficient to cover any tax, assessment or other governmental charge payable in
connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Prior to due presentment
of this Note for registration of transfer, the Company, the Trustee or any of their agents shall&nbsp;treat the Person in whose
name this Note is registered as the owner hereof for all purposes, whether or not this Note be overdue, and neither the Company,
the Trustee nor any of their agents shall be affected by notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture contains
provisions whereby (i) the Indenture shall cease to be of further effect with respect to the Notes (subject to the survival of
certain provisions thereof), (ii) the Company may be discharged from its obligations with respect to the Notes (subject to certain
exceptions), or (iii) the Company may be released from its obligations under specified covenants and agreements in the Indenture,
in each case if the Company satisfies certain conditions provided in the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No recourse shall be
had for the payment of the principal of, premium, if any, or interest on, this Note or for any claim based hereon or otherwise
in respect hereof or of the Debt represented hereby, or upon any obligation, covenant or agreement of the Indenture, against any
incorporator, stockholder, officer or director, as such, past, present or future, of the Company or of any successor corporation,
either directly or through the Company or any successor corporation, whether by virtue of any constitutional provision, statute
or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly agreed and understood that
the Indenture and this Note are solely corporate obligations, and that no personal liability whatsoever shall attach to, or be
incurred by, any incorporator, stockholder, officer or director, as such, past, present or future, of the Company or of any successor
corporation, either directly or through the Company or any successor corporation, because of the incurring of the Debt pursuant
to this Note or under or by reason of any of the obligations, covenants, promises or agreements contained in the Indenture or in
this Note, or to be implied herefrom, and that all liability, if any, of that character against every such incorporator, stockholder,
officer and director is, by the acceptance of this Note and as a condition of, and as part of the consideration for, the execution
of the Indenture and the issue of this Note expressly waived and released.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THE INDENTURE AND THE
NOTE SHALL BE DEEMED TO BE A CONTRACT MADE UNDER THE LAWS OF THE STATE OF NEW YORK, AND FOR ALL PURPOSES SHALL BE CONSTRUED IN
ACCORDANCE WITH THE LAWS OF SAID STATE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to a recommendation
promulgated by the Committee on Uniform&nbsp;Security Identification Procedures, the Company has caused CUSIP numbers to be printed
on the Notes as a convenience to the Holders of the Notes. No representation is made as to the correctness or accuracy of such
CUSIP numbers as printed on the Notes, and reliance may&nbsp;be placed only on the other identification numbers printed hereon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All terms used in this
Note which are defined in the Indenture shall have the meanings assigned to them in the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ASSIGNMENT FORM<BR>
FOR VALUE RECEIVED, THE UNDERSIGNED HEREBY<BR>
SELLS, ASSIGNS AND TRANSFERS TO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PLEASE INSERT SOCIAL<BR>
SECURITY OR OTHER IDENTIFYING<BR>
NUMBER OF ASSIGNEE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Please Print or Typewrite Name and Address<BR>
including Zip Code of Assignee)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">the within Note of&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</U> and&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> hereby does irrevocably constitute and appoint</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border-bottom: Black 0.5pt solid"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Attorney to transfer said Note
on the books of the within-named Company with full power of substitution in the premises.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Dated:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 7%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 19%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 14%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 38%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 19%; text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOTICE: The signature to this assignment
must correspond with the name as it appears on the first page&nbsp;of the within Note in every particular, without alteration or
enlargement or any change whatever.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 22; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>tm2023139d1_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 5.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="tm2023139d1_ex5-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">June 23, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Healthpeak Properties, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">1920 Main Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Suite 1200</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Irvine, California 92614</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 95%; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">Re:</TD><TD STYLE="text-align: justify">Healthpeak Properties, Inc. (formerly known as HCP, Inc.), a Maryland corporation (the &quot;Company&quot;)
- Sale of $600,000,000 aggregate principal amount of 2.875% Senior Notes Due 2031 (the &quot;Notes&quot;) pursuant to a Registration
Statement on Form S-3 (Registration No. 333-225318) (the &quot;Registration Statement&quot;)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">We have acted as Maryland
corporate counsel to the Company in connection with the registration of the Notes under the Securities Act of 1933, as amended
(the &quot;Act&quot;), under the Registration Statement, which was filed with the Securities and Exchange Commission (the &quot;Commission&quot;)
on or about May 31, 2018. You have requested our opinion with respect to the matters set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">In our capacity as Maryland
corporate counsel to the Company and for the purposes of this opinion, we have examined originals, or copies certified or otherwise
identified to our satisfaction, of the following documents (collectively, the &quot;Documents&quot;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">1.</FONT></TD><TD STYLE="text-align: justify">the corporate charter of the Company (the &quot;Charter&quot;), consisting of Articles of Restatement
filed with the State Department of Assessments and Taxation of Maryland (the &quot;Department&quot;) on June 1, 2012, Articles
of Merger filed with the Department on December 3, 2015, Articles Supplementary filed with the Department on July 31, 2017 and
Articles of Amendment filed with the Department on October 30, 2019;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">2.</FONT></TD><TD STYLE="text-align: justify">the Fifth Amended and Restated Bylaws of the Company, dated as of February 8, 2015, as amended
by Amendment No. 1 to Fifth Amended and Restated Bylaws of the Company, dated as of January 28, 2016, and Amendment No. 2 to Fifth
Amended and Restated Bylaws of the Company, dated as of July 27, 2017, and the Sixth Amended and Restated Bylaws of the Company,
dated as of October 30, 2019 (the &quot;Bylaws&quot;);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">3.</FONT></TD><TD STYLE="text-align: justify">the Minutes of the Organizational Action of the Board of Directors of the Company, dated March
21, 1985 (the &quot;Organizational Minutes&quot;);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">4.</FONT></TD><TD STYLE="text-align: justify">resolutions adopted by the Board of Directors of the Company, or a duly authorized committee thereof,
on May 23, 2018, June 8, 2020 and June 9, 2020, which, among other things,
authorized the issuance of the Notes (collectively, the &quot;Directors' Resolutions&quot;);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin-left: 0.25in; font-size: 10pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><B>BALLARD
                                         SPAHR LLP</B></P><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P><P STYLE="margin-left: 0.25in; font-size: 10pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Healthpeak Properties, Inc.</P><P STYLE="margin-left: 0.25in; font-size: 10pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt">June 23, 2020</P><P STYLE="margin-left: 0.25in; font-size: 10pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">5.</FONT></TD><TD STYLE="text-align: justify">the Indenture, dated as of November 19, 2012 (the &quot;Base Indenture&quot;), as supplemented
by the First Supplemental Indenture, dated as of November 19, 2012 (the &quot;First Supplemental Indenture&quot;), the Second Supplemental
Indenture, dated as of November 12, 2013 (the &quot;Second Supplemental Indenture&quot;), the Third Supplemental Indenture, dated
as of February 21, 2014 (the &#8220;Third Supplemental Indenture&#8221;), the Fourth Supplemental Indenture, dated as of August
14, 2014 (the &#8220;Fourth Supplemental Indenture&#8221;), the Fifth Supplemental Indenture, dated as of January 21, 2015 (the
 &#8220;Fifth Supplemental Indenture&#8221;), the Sixth Supplemental Indenture, dated as of May 20, 2015 (the &#8220;Sixth Supplemental
Indenture&#8221;), the Seventh Supplemental Indenture, dated as of December 1, 2015 (the &quot;Seventh Supplemental Indenture&quot;),
the Eighth Supplemental Indenture, dated as of July 5, 2019 (the &quot;Eighth Supplemental Indenture&quot;), the Ninth Supplemental
Indenture, dated as of November 21, 2019 (the &quot;Ninth Supplemental Indenture&quot;), and the form of Tenth Supplemental Indenture
(the &quot;Tenth Supplemental Indenture&quot; and together with the First Supplemental Indenture, the Second Supplemental Indenture,
the Third Supplemental Indenture, the Fourth Supplemental Indenture, the Fifth Supplemental Indenture, the Sixth Supplemental Indenture,
the Seventh Supplemental Indenture, the Eighth Supplemental Indenture, the Ninth Supplemental Indenture and the Base Indenture,
collectively, the &quot;Indenture&quot;), by and between the Company and The Bank of New York Mellon Trust Company, N.A., and the
form of the Notes attached to the Tenth Supplemental Indenture;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">6.</FONT></TD><TD STYLE="text-align: justify">a certificate of Peter A. Scott, the Executive Vice President and Chief Financial Officer of the
Company, and Troy E. McHenry, the Executive Vice President, Chief Legal Officer and Corporate Secretary of the Company, dated as
of June 23, 2020 (the &quot;Officers' Certificate&quot;), to the effect that, among other things, the copies of the Charter, the
Bylaws, the Organizational Minutes and the Directors' Resolutions are true, correct and complete, have not been rescinded or modified
and are in full force and effect on the date of the Officers' Certificate, and certifying as to the form of the Indenture;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">7.</FONT></TD><TD STYLE="text-align: justify">the Registration Statement and the related base prospectus and prospectus supplement included therein,
in substantially the form filed or to be filed with the Commission pursuant to the Act;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">8.</FONT></TD><TD STYLE="text-align: justify">a status certificate of the Department, dated June 8, 2020, to the effect that the Company is duly
incorporated and existing under the laws of the State of Maryland; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">9.</FONT></TD><TD STYLE="text-align: justify">such other laws, records, documents, certificates, opinions and instruments as we have deemed necessary
to render this opinion, subject to the limitations, assumptions and qualifications noted below.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin-left: 0.25in; font-size: 10pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><B>BALLARD
                                         SPAHR LLP</B></P><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P><P STYLE="margin-left: 0.25in; font-size: 10pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Healthpeak Properties, Inc.</P><P STYLE="margin-left: 0.25in; font-size: 10pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt">June 23, 2020</P><P STYLE="margin-left: 0.25in; font-size: 10pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">In reaching the opinions
set forth below, we have assumed the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(a)</FONT></TD><TD STYLE="text-align: justify">each person executing any instrument, document or agreement on behalf of any party (other than
the Company) is duly authorized to do so;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(b)</FONT></TD><TD STYLE="text-align: justify">each natural person executing any instrument, document or agreement is legally competent to do
so;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(c)</FONT></TD><TD STYLE="text-align: justify">all Documents submitted to us as originals are authentic; the form and content of all Documents
submitted to us as unexecuted drafts do not, and will not, differ in any respect relevant to this opinion from the form and content
of such documents as executed and delivered; all Documents submitted to us as certified or photostatic copies conform to the original
documents; all signatures on all Documents are genuine; all public records reviewed or relied upon by us or on our behalf are true
and complete; all representations, warranties, statements and information contained in the Documents are true and complete; there
has been no modification of, or amendment to, any of the Documents, and there has been no waiver of any provision of any of the
Documents by action or omission of the parties or otherwise;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(d)</FONT></TD><TD STYLE="text-align: justify">all certificates submitted to us, including but not limited to the Officers' Certificate, are true,
correct and complete both when made and as of the date hereof;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(e)</FONT></TD><TD STYLE="text-align: justify">prior to the issuance of the Notes, the Tenth Supplemental Indenture will be duly executed and
delivered to the Trustee (as defined in the Indenture) by the Company; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(f)</FONT></TD><TD STYLE="text-align: justify">the Indenture will remain in full force and effect for so long as the Notes are outstanding.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Based on the foregoing,
and subject to the assumptions and qualifications set forth herein, it is our opinion that, as of the date of this letter:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(i)</FONT></TD><TD STYLE="text-align: justify">The Company has been duly incorporated and is validly existing as a corporation in good standing
under the laws of the State of Maryland.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(ii)</FONT></TD><TD STYLE="text-align: justify">The Company has the corporate power to create the obligation evidenced by the Notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(iii)</FONT></TD><TD STYLE="text-align: justify">The Notes have been duly authorized for issuance by the Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin-left: 0.25in; font-size: 10pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><B>BALLARD
                                         SPAHR LLP</B></P><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P><P STYLE="margin-left: 0.25in; font-size: 10pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Healthpeak Properties, Inc.</P><P STYLE="margin-left: 0.25in; font-size: 10pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt">June 23, 2020</P><P STYLE="margin-left: 0.25in; font-size: 10pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The foregoing opinion is
limited to the substantive laws of the State of Maryland, and we do not express any opinion herein concerning any other law.
We express no opinion as to the applicability or effect of any federal or state securities laws, including the securities
laws of the State of Maryland, or as to federal or state laws regarding fraudulent transfers. To the extent that any matter
as to which our opinion is expressed herein would be governed by the laws of any jurisdiction other than the State of
Maryland, we do not express any opinion on such matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">This opinion letter is
issued as of the date hereof and is necessarily limited to laws now in effect and facts and circumstances presently existing and
brought to our attention. We assume no obligation to supplement this opinion letter if any applicable laws change after the date
hereof, or if we become aware of any facts or circumstances that now exist or that occur or arise in the future and may change
the opinions expressed herein after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">We consent to the incorporation
by reference of this opinion in the Registration Statement and further consent to the filing of this opinion as an exhibit to the
applications to securities commissioners for the various states of the United States for registration of the Notes. We also consent
to the identification of our firm as Maryland counsel to the Company in the section of the Registration Statement entitled &quot;Legal
Matters&quot;. In giving this consent, we do not admit that we are within the category of persons whose consent is required by
Section 7 of the Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; margin-left: 0.25in">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">/s/ Ballard Spahr LLP</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.2
<SEQUENCE>4
<FILENAME>tm2023139d1_ex5-2.htm
<DESCRIPTION>EXHIBIT 5.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 5.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[Letterhead of Skadden, Arps, Slate, Meagher
 &amp; Flom LLP]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">June 23, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Healthpeak Properties, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1920 Main Street, Suite 1200</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Irvine, CA 92614</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">Re:</TD><TD><U>Healthpeak Properties, Inc. Senior Notes Offering</U></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">We have acted as special United States counsel
to Healthpeak Properties, Inc., a Maryland corporation (the &ldquo;<U>Company</U>&rdquo;), in connection with the public offering
of $600,000,000 aggregate principal amount of the Company&rsquo;s 2.875% Senior Notes due 2031 (the &ldquo;<U>Securities</U>&rdquo;)
to be issued under the Indenture, dated as of November 19, 2012 (the &ldquo;<U>Base Indenture</U>&rdquo;), as amended and supplemented
by the Tenth Supplemental Indenture, dated as of June 23, 2020 (together with the Base Indenture, the &ldquo;<U>Indenture</U>&rdquo;),
by and between the Company and The Bank of New York Mellon Trust Company N.A., as trustee (the &ldquo;<U>Trustee</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">This opinion is being furnished in accordance
with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act of 1933, as amended (the &ldquo;<U>Securities
Act</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">In rendering the opinion stated herein, we
have examined and relied upon the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the registration statement on Form S-3 (File No. 333-225318) of the Company relating to debt securities and other securities
of the Company filed on May 31, 2018 with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) under the
Securities Act allowing for delayed offerings pursuant to Rule 415 of the General Rules and Regulations under the Securities Act
(the &ldquo;<U>Rules and Regulations</U>&rdquo;) including the information deemed to be a part of the registration statement pursuant
to Rule 430B of the Rules and Regulations (such registration statement being hereinafter referred to as the &ldquo;<U>Registration
Statement</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the prospectus, dated May 31, 2018 (the &ldquo;<U>Base Prospectus</U>&rdquo;), which forms a part of and is included in
the Registration Statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the preliminary prospectus supplement, dated June 9, 2020 (together with the Base Prospectus, the &ldquo;<U>Preliminary
Prospectus</U>&rdquo;), relating to the offering of the Securities, in the form filed with the Commission pursuant to Rule 424(b)
of the Rules and Regulations;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Healthpeak Properties, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">June 23, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> the prospectus supplement, dated June 9, 2020 (together with the Base Prospectus, the &ldquo;<U>Prospectus</U>&rdquo;),
relating to the offering of the Securities, in the form filed with the Commission pursuant to Rule 424(b) of the Rules and Regulations;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>an executed copy of the Underwriting Agreement, dated June 9, 2020 (the &ldquo;<U>Underwriting Agreement</U>&rdquo;), among
the Company and Wells Fargo Securities, LLC, Barclays Capital Inc., BofA Securities Inc. and Morgan Stanley &amp; Co. LLC, as representatives
of the several Underwriters named therein (the &ldquo;<U>Underwriters</U>&rdquo;), relating to the sale by the Company to the Underwriters
of the Securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>an executed copy of the Indenture; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the global certificates evidencing the Securities registered in the name of Cede &amp; Co. (the &ldquo;<U>Note Certificates</U>&rdquo;)
in the form delivered by the Company to the Trustee for authentication and delivery.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">We have also examined originals or copies,
certified or otherwise identified to our satisfaction, of such records of the Company and such agreements, certificates and receipts
of public officials, certificates of officers or other representatives of the Company and others, and such other documents as we
have deemed necessary or appropriate as a basis for the opinion stated below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">In our examination, we have assumed the genuineness
of all signatures, including electronic signatures, the legal capacity and competency of all natural persons, the authenticity
of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as facsimile,
electronic, certified or photocopied copies, and the authenticity of the originals of such copies. As to any facts relevant to
the opinion stated herein that we did not independently establish or verify, we have relied upon statements and representations
of officers and other representatives of the Company and others and of public officials, including the factual representations
and warranties contained in the Underwriting Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">We do not express any opinion with respect
to the laws of any jurisdiction other than the laws of the State of New York (the &ldquo;<U>Opined-on Law</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">As used herein, &ldquo;<U>Transaction Documents</U>&rdquo;
means the Underwriting Agreement, the Indenture and the Note Certificates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Based upon the foregoing and subject to the
qualifications and assumptions stated herein, we are of the opinion that when the Note Certificates have been duly executed by
the Company and when duly authenticated by the Trustee and issued and delivered by the Company against payment therefor in accordance
with the terms of the Underwriting Agreement and the Indenture, the Note Certificates will constitute valid and binding obligations
of the Company, enforceable against the Company in accordance with their terms under the laws of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Healthpeak Properties, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">June 23, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 3</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The opinion stated herein is subject to the
following qualifications:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the opinion stated herein is limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent transfer,
preference and other similar laws affecting creditors&rsquo; rights generally, and by general principles of equity (regardless
of whether enforcement is sought in equity or at law);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>we do not express any opinion with respect to any law, rule or regulation that is applicable to any party to any of the
Transaction Documents or the transactions contemplated thereby solely because such law, rule or regulation is part of a regulatory
regime applicable to any such party or any of its affiliates as a result of the specific assets or business operations of such
party or such affiliates;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>except to the extent expressly stated in the opinion contained herein, we have assumed that each of the Transaction Documents
constitutes the valid and binding obligation of each party to such Transaction Agreement, enforceable against such party in accordance
with its terms;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>we do not express any opinion with respect to the enforceability of any provision contained in any Transaction Agreement
relating to any indemnification, contribution, exculpation, release or waiver that may be contrary to public policy or violative
of federal or state securities laws, rules or regulations;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>we call to your attention that irrespective of the agreement of the parties to any Transaction Agreement, a court may decline
to hear a case on grounds of forum non conveniens or other doctrine limiting the availability of such court as a forum for resolution
of disputes; in addition, we call to your attention that we do not express any opinion with respect to the subject matter jurisdiction
of the federal courts of the United States of America in any action arising out of or relating to any Transaction Agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>to the extent that any opinion relates to the enforceability of the choice of New York law and choice of New York forum
provisions contained in any Transaction Agreement, the opinion stated herein is subject to the qualification that such enforceability
may be subject to, in each case, (i) the exceptions and limitations in New York General Obligations Law sections 5-1401 and 5-1402
and (ii) principles of comity or constitutionality.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">In addition, in rendering the foregoing opinion
we have assumed that, at all applicable times:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Company (i) was duly incorporated and was validly existing and in good standing, (ii) had requisite legal status and
legal capacity under the laws of the jurisdiction of its organization and (iii) has complied and will comply with all aspects of
the laws of the jurisdiction of its organization in connection with the transactions contemplated by, and the performance of its
obligations under, the Transaction Documents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Healthpeak Properties, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">June 23, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 4</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> the Company had the corporate power and authority to execute, deliver and perform all its obligations under each of the
Transaction Documents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>each of the Transaction Documents had been duly authorized, executed and delivered by all requisite corporate action on
the part of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>neither the execution and delivery by the Company of the Transaction Documents nor the performance by the Company of its
obligations thereunder, including the issuance and sale of the Securities: (i) conflicted or will conflict with the certificate
of incorporation, by-laws or any other comparable organizational document of the Company, (ii) constituted or will constitute a
violation of, or a default under, any lease, indenture, instrument or other agreement to which the Company or its property is subject
(except that we do not make the assumption set forth in this clause (ii) with respect to those agreements or instruments which
are listed in Part II of the Registration Statement or listed in the exhibits to the Company&rsquo;s Annual Report on Form 10-K),
(iii) contravened or will contravene any order or decree of any governmental authority to which the Company or its property is
subject, or (iv) violated or will violate any law, rule or regulation to which the Company or its property is subject (except that
we do not make the assumption set forth in this clause (iv) with respect to the Opined-on Law); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>neither the execution and delivery by the Company of the Transaction Documents nor the performance by the Company of its
obligations thereunder, including the issuance and sale of the Securities, required or will require the consent, approval, licensing
or authorization of, or any filing, recording or registration with, any governmental authority under any law, rule or regulation
of any jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">We hereby consent to the reference to our
firm under the heading &ldquo;Legal Matters&rdquo; in the Preliminary Prospectus and the Prospectus. In giving this consent, we
do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act
or the Rules and Regulations. We also hereby consent to the filing of this opinion with the Commission as an exhibit to the Company&rsquo;s
Current Report on Form 8-K being filed on the date hereof and incorporated by reference into the Registration Statement. This opinion
is expressed as of the date hereof unless otherwise expressly stated, and we disclaim any undertaking to advise you of any subsequent
changes in the facts stated or assumed herein or of any subsequent changes in applicable laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; width: 50%">/s/ Skadden, Arps, Slate, Meagher &amp; Flom LLP</TD>
    <TD STYLE="padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt; width: 50%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8.1
<SEQUENCE>5
<FILENAME>tm2023139d1_ex8-1.htm
<DESCRIPTION>EXHIBIT 8.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 8.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Letterhead of Skadden, Arps, Slate, Meagher
 &amp; Flom LLP]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;<B>&nbsp;</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">June&nbsp;23, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Healthpeak Properties, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1920 Main Street, Suite 1200</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Irvine, CA 92614</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">Re:</TD><TD STYLE="padding-right: 0.9pt"><U>Certain United States Federal Income Tax Matters</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.9pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">We have acted as United States federal income
tax counsel to Healthpeak Properties,&nbsp;Inc., a Maryland corporation (&#8220;<U>Healthpeak</U>&#8221; and, collectively with
the entities in which Healthpeak holds, or has held, a direct or indirect interest, the &#8220;<U>Company</U>&#8221;), in connection
with the Underwriting Agreement, dated June&nbsp;9, 2020 (the &#8220;<U>Underwriting Agreement</U>&#8221;), between Wells Fargo
Securities, LLC, Barclays Capital Inc., BofA Securities, Inc., and Morgan Stanley &amp; Co. LLC, as representatives of the several
underwriters named therein (the &#8220;<U>Underwriters</U>&#8221;), and the Company, relating to the sale by the Company to the
Underwriters of $600,000,000 aggregate principal amount of the Company&#8217;s 2.875% Senior Notes due 2031 (the &#8220;<U>Securities</U>&#8221;)
to be issued under the Indenture, dated as of November&nbsp;19, 2012 (the &#8220;<U>Base Indenture</U>&#8221;), as amended and
supplemented by the Tenth Supplemental Indenture, dated as of June&nbsp;23, 2020 (the &#8220;<U>Supplemental Indenture</U>&#8221;
and, together with the Base Indenture, the &#8220;<U>Indenture</U>&#8221;), by and between the Company and The Bank of New York
Mellon Trust Company N.A. The Underwriting Agreement and the Indenture are collectively referred to herein as the &#8220;<U>Transaction
Documents</U>.&#8221;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The Securities are being offered
pursuant to (i)&nbsp;a registration statement on Form S-3 (File No. 333-225318) relating to the Securities and other
securities of Healthpeak filed on May&nbsp;31, 2018 with the Securities and Exchange Commission (the
 &#8220;<U>Commission</U>&#8221;) under the Securities Act of 1933, as amended (the &#8220;<U>Securities Act</U>&#8221;),
allowing for delayed offerings pursuant to Rule 415 of the General Rules and Regulations under the Securities Act (the
 &#8220;<U>Rules and Regulations</U>&#8221;), including the information deemed to be a part of the registration statement
pursuant to Rule 430B of the Rules and Regulations (such registration statement, the &#8220;<U>Registration
Statement</U>&#8221;); (ii)&nbsp;a prospectus, dated May&nbsp;31, 2018 (the &#8220;<U>Base Prospectus</U>&#8221;), which
forms a part of and is included in the Registration Statement; and (iii)&nbsp;a prospectus supplement, dated June&nbsp;9,
2020, relating to the offering of the Securities, in the form filed by Healthpeak with the Commission pursuant to Rule 424(b)
of the Rules and Regulations (the &#8220;<U>Prospectus Supplement</U>&#8221; and, together with the Base Prospectus, the
 &#8220;<U>Prospectus</U>&#8221;). The Transaction Documents, the Registration Statement, and the Prospectus are collectively
referred to herein as the &#8220;<U>Offering Documents</U>.&#8221;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Healthpeak Properties, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">June 23, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 2</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">This opinion is being furnished in accordance
with the requirements of Item&nbsp;601(b)(8) of Regulation S-K under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">In connection with this opinion, we have examined
originals or copies, certified or otherwise identified to our satisfaction, of the Offering Documents and such other documentation
and information provided to us by you as we have deemed necessary or appropriate as a basis for the opinion set forth herein. In
addition, you have provided us with, and we are relying upon, a certificate containing certain factual statements, factual representations
and covenants of officers of Healthpeak (the &#8220;<U>Officers&#8217; Certificate</U>&#8221;) relating to, among other things,
the actual and proposed operations of the Company. These representations and covenants relate, in some cases, to transactions and
investments for which we did not act as the Company&#8217;s primary counsel. For purposes of our opinion, we have not independently
verified all of the facts, statements, representations and covenants set forth in the Officers&#8217; Certificate, the Offering
Documents or in any other document. In particular, we note that the Company may engage in transactions in which we have not provided
legal advice, and have not reviewed, and of which we may be unaware. We have, consequently, assumed and relied on your representation
that the statements, representations and covenants contained in the Officers&#8217; Certificate, the Offering Documents, and other
documents, or otherwise furnished to us, accurately and completely describe all material facts relevant to such statements, representations,
and covenants. We have assumed that such facts, statements, representations and covenants are true without regard to any qualification
as to knowledge, belief, intent or materiality. Our opinion is conditioned on the continuing accuracy and completeness of such
facts, statements, representations and covenants. We are not aware of any facts inconsistent with such statements, representations
and covenants. Any material change or inaccuracy in the facts referred to, set forth or assumed herein or in the Officers&#8217;
Certificate may affect our conclusions set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">In our review of certain documents in connection
with our opinion as expressed below, we have assumed the legal capacity of all natural persons, the genuineness of all signatures,
the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted
to us as certified, conformed, photostatic or electronic copies, and the authenticity of the originals of such copies. Where documents
have been provided to us in draft form, we have assumed that the final executed versions of such documents will not differ materially
from such drafts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Our opinion is also based on the correctness
of the following assumptions: (i)&nbsp;Healthpeak and each of the entities comprising the Company has been and will continue to
be operated in accordance with the laws of the jurisdiction in which it was formed and in the manner described in the relevant
organizational documents, (ii)&nbsp;there will be no changes in the applicable laws of the State of Maryland or of any other jurisdiction
under the laws of which any of the entities comprising the Company have been formed and (iii)&nbsp;each of the written agreements
to which the Company is a party has been and will be implemented, construed and enforced in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Healthpeak Properties, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">June 23, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 3</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">In rendering our opinion, we have considered
and relied upon the Internal Revenue Code of 1986, as amended (the &#8220;<U>Code</U>&#8221;), the regulations promulgated thereunder
(&#8220;<U>Regulations</U>&#8221;), administrative rulings and other Treasury interpretations of the Code and the Regulations by
the courts and the Internal Revenue Service, all as they exist at the date hereof. It should be noted that the Code, Regulations,
judicial decisions and administrative interpretations are subject to change at any time and, in some circumstances, with retroactive
effect. A material change that is made after the date hereof in any of the foregoing bases for our opinion could affect our conclusions
set forth herein. There can be no assurance, moreover, that our opinion will be accepted by the Internal Revenue Service or, if
challenged, by a court.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Based on and subject to the foregoing, we
are of the opinion that commencing with Healthpeak&#8217;s taxable year that ended on December&nbsp;31, 1985, Healthpeak has been
organized and operated in conformity with the requirements for qualification as a real estate investment trust (a &#8220;<U>REIT</U>&#8221;)
under the Code, and its actual method of operation through the date of this opinion has enabled, and its proposed method of operation
will continue to enable, it to meet the requirements for qualification and taxation as a REIT under the Code thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in">As noted in the Prospectus, Healthpeak&#8217;s
qualification and taxation as a REIT depend upon its ability to meet, through actual operating results, certain requirements relating
to the sources of its income, the nature of its assets, distribution levels and diversity of stock ownership, and various other
qualification tests imposed under the Code, the results of which are not reviewed by us. Accordingly, no assurance can be given
that the actual results of Healthpeak&#8217;s operation for any one taxable year will satisfy the requirements for taxation as
a REIT under the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">This opinion is furnished only to you in connection
with the Offering Documents. We hereby consent to the filing of this opinion with the Commission as an exhibit to Healthpeak&#8217;s
Current Report on Form 8-K, being filed on the date hereof. In giving this consent, we do not thereby admit that we are within
the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the Rules and Regulations. Except
as set forth above, we express no other opinion. This opinion is expressed as of the date hereof, and we are under no obligation
to supplement or revise our opinion to reflect any legal developments or factual matters arising subsequent to the date hereof,
or the impact of any information, document, certificate, record, statement, representation, covenant or assumption relied upon
herein that becomes incorrect or untrue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3in">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; width: 50%">/s/ Skadden, Arps, Slate, Meagher &amp; Flom LLP</TD>
    <TD STYLE="padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt; width: 50%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>tm2023139d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="tm2023139d1_ex99-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Healthpeak Properties&trade; Announces Early Tender Results
of Tender Offer for Outstanding Notes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">IRVINE, Calif., June 23, 2020 /PRNewswire/ -- Healthpeak Properties,
Inc. (NYSE: PEAK) (&ldquo;Healthpeak&rdquo;) announced today the early tender results for its previously announced tender offer
(the &ldquo;Tender Offer&rdquo;) to purchase for cash up to an aggregate principal amount of $250,000,000 (the &ldquo;Aggregate
Maximum Tender Amount&rdquo;) of its 4.250% Senior Notes due 2023 (the &ldquo;Notes&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: bottom; width: 12%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Title of Note</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 12%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>CUSIP <BR>
Number</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 19%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Principal <BR>
Amount <BR>
Outstanding</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 11%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Aggregate<BR>
 Maximum<BR>
 Tender<BR>
 Amount</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 10%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>U.S.<BR>
 Treasury<BR>
 Reference <BR>
Security</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 10%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Bloomberg<BR>
 Reference<BR>
 Page</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 8%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Fixed<BR>
 Spread</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 9%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Early<BR>
 Tender<BR>
 Premium<BR>
 (1)</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 9%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Principal<BR>
 Amount<BR>
 Tendered at<BR>
 Early<BR>
 Tender<BR>
 Time</B></FONT></TD></TR>
<TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">4.250% Senior Notes due 2023</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">40414LAJ8</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">$550,000,000</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">$250,000,000</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">0.125% UST due 5/15/2023</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">FIT1</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">+95 bps</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">$30</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">$264,517,000</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>Per $1,000 principal amount.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The terms and conditions of the Tender Offer
are set forth in the offer to purchase, dated June 9, 2020, as amended on June 9, 2020 (as the same may be further amended or supplemented,
the &ldquo;Offer to Purchase&rdquo;). The Tender Offer will expire at 12:00 midnight, New York City Time, at the end of July 7,
2020, unless earlier terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of 5:00 p.m., New York City Time, on
June 22, 2020 (such date and time, as it may be extended, the &ldquo;Early Tender Time&rdquo;), according to information provided
by Global Bondholder Services Corporation, the tender and information agent for the Tender Offer, the aggregate principal amount
of the Notes set forth in the table above under &ldquo;Principal Amount Tendered at Early Tender Time&rdquo; had been validly tendered
and not validly withdrawn in the Tender Offer. Withdrawal rights for the Notes expired at 5:00 p.m., New York City Time, on June
22, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The &ldquo;Total Consideration&rdquo; for
each $1,000 principal amount of Notes validly tendered and accepted for purchase pursuant to the Tender Offer will be determined
in the manner described in the Offer to Purchase by reference to the fixed spread for the Notes specified in the table above plus
the yield based on the bid-side price of the U.S. Treasury Reference Security specified in the table above at 10:00 a.m., New York
City Time, today, and is inclusive of the Early Tender Premium (as set forth in the table above).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Healthpeak expects to announce the pricing
of the Tender Offer, the amount of Notes accepted for purchase, and the proration rates for the Notes later today.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Only holders of Notes who validly tendered
and did not validly withdraw their Notes at or prior to the Early Tender Time are eligible to receive the Total Consideration for
the Notes accepted for purchase. Holders of Notes will also receive accrued and unpaid interest on their Notes validly tendered
and accepted for purchase from the last interest payment date up to, but not including, the settlement date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Healthpeak has satisfied the financing condition
to the Tender Offer and, on June 24, 2020, expects to pay for the Notes that were validly tendered prior to or at the Early Tender
Time and that are accepted for purchase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2023139d1_ex99-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Since the Tender Offer for the Notes was
fully subscribed as of the Early Tender Time, Healthpeak will not accept for purchase any Notes validly tendered after the Early
Tender Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Information Relating to the Tender Offer</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Wells Fargo Securities and Barclays are
serving as the dealer managers for the Tender Offer. Investors with questions regarding the Tender Offer may contact Wells Fargo
Securities at (704) 410-4759 (collect) or (866) 309-6316 (toll-free) or Barclays at (212) 528-7581 (collect) or (800) 438-3242
(toll-free).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">None of Healthpeak or its affiliates, their
respective boards of directors, the dealer managers, the tender and information agent or the trustee with respect to the Notes
is making any recommendation as to whether holders should tender any Notes in response to the Tender Offer, and neither Healthpeak
nor any such other person has authorized any person to make any such recommendation. Holders must make their own decision as to
whether to tender any of their Notes, and, if so, the principal amount of Notes to tender.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This press release is for informational
purposes only and is not an offer to buy, or the solicitation of an offer to sell, any of the Notes and the Tender Offer does
not constitute an offer to buy or the solicitation of an offer to sell the Notes in any jurisdiction or in any circumstances in
which such offer or solicitation are unlawful. The full details of the Tender Offer are included in the Offer to Purchase. Holders
are strongly encouraged to carefully read the Offer to Purchase, including materials incorporated by reference therein, because
they contain important information. The Offer to Purchase may be downloaded from Global Bondholder Services Corporation&rsquo;s
website at <U>www.gbsc-usa.com/healthpeak/</U> or obtained from Global Bondholder Services Corporation, free of charge, by calling
toll-free at (866) 470-4500 (bankers and brokers can call collect at (212) 430-3774).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Healthpeak</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Healthpeak Properties, Inc. is a fully integrated
real estate investment trust (REIT) and S&amp;P 500 company. Healthpeak owns and develops high-quality real estate in the three
private-pay healthcare asset classes of Life Science, Senior Housing and Medical Office, designed to provide stability through
the inevitable industry cycles. At Healthpeak, we pair our deep understanding of the healthcare real estate market with a strong
vision for long-term growth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This press release contains forward-looking
statements within the meaning of federal securities laws and regulations. These forward-looking statements are identified by their
use of terms and phrases such as &ldquo;believe,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;project,&rdquo; &ldquo;anticipate,&rdquo;
 &ldquo;position,&rdquo; and other similar terms and phrases, including references to assumptions and forecasts of future results.
Forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other
factors which may cause the actual results to differ materially from those anticipated at the time the forward-looking statements
are made. These risks and uncertainties include, but are not limited to, Healthpeak&rsquo;s ability to complete the Tender Offer
and reduce its outstanding debt within expected time-frames or at all, and other risks and uncertainties described in the Offer
to Purchase and in its Securities and Exchange Commission filings. Although Healthpeak believes the expectations reflected in such
forward-looking statements are based upon reasonable assumptions, Healthpeak can give no assurance that the expectations will be
attained or that any deviation will not be material. All information in this release is as of the date of this release, and Healthpeak
undertakes no obligation to update any forward-looking statement to conform the statement to actual results or changes in its expectations,
except as required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Contact</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Barbat Rodgers</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Senior Director &ndash; Investor Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(949) 407-0400</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>7
<FILENAME>tm2023139d1_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="tm2023139d1_ex99-2img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Healthpeak Properties&trade; Announces Pricing of Tender
Offer </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">IRVINE, Calif., June 23, 2020 /PRNewswire/ -- Healthpeak Properties,
Inc. (NYSE: PEAK) (&ldquo;Healthpeak&rdquo;) announced today the consideration payable in connection with its previously announced
tender offer (the &ldquo;Tender Offer&rdquo;) to purchase for cash up to an aggregate principal amount of $250,000,000 (the &ldquo;Aggregate
Maximum Tender Amount&rdquo;) of its 4.250% Senior Notes due 2023 (the &ldquo;Notes&rdquo;) as described in the table below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 12%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Title of Note</B></FONT></TD>
    <TD STYLE="width: 12%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>CUSIP<BR>
Number</B></FONT></TD>
    <TD STYLE="width: 19%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Principal<BR>
Amount<BR>
Outstanding</B></FONT></TD>
    <TD STYLE="width: 11%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Aggregate<BR>
Maximum<BR>
Tender<BR>
Amount</B></FONT></TD>
    <TD STYLE="width: 10%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>U.S.<BR>
Treasury<BR>
Reference<BR>
Security</B></FONT></TD>
    <TD STYLE="width: 10%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Bloomberg<BR>
Reference<BR>
Page</B></FONT></TD>
    <TD STYLE="width: 8%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Fixed<BR>
Spread</B></FONT></TD>
    <TD STYLE="width: 9%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Early<BR>
Tender<BR>
Premium<BR>
(1)(2)</B></FONT></TD>
    <TD STYLE="width: 9%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Total<BR>
Consideration<BR>
(1)(2)</B></FONT></TD></TR>
<TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">4.250% Senior Notes due 2023</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">40414LAJ8</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">$550,000,000</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">$250,000,000</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">0.125% UST due 5/15/2023</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">FIT1</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">+95 bps</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">$30</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">$1,094.93</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>Per $1,000 principal amount.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>The Total Consideration for Notes validly tendered prior to or at the Early Tender Time (as defined below) and accepted for
purchase is calculated using the applicable Fixed Spread (as set forth in the table above) and is inclusive of the Early Tender
Premium (as set forth in the table above).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Tender Offer was made on the terms and
conditions set forth in the Offer to Purchase, dated June 9, 2020, as amended on June 9, 2020 (as the same may be further amended
or supplemented, the &ldquo;Offer to Purchase&rdquo;). The Tender Offer will expire at 12:00 midnight, New York City Time, at the
end of July 7, 2020, unless earlier terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The &ldquo;Total Consideration&rdquo; for
each $1,000 principal amount of the Notes validly tendered and accepted for purchase pursuant to the Tender Offer was determined
in the manner described in the Offer to Purchase by reference to the fixed spread for the Notes specified in the table above plus
the yield based on the bid-side price of the U.S. Treasury Reference Security specified in the table above at 10:00 a.m., New York
City Time, today.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Only holders of Notes who validly tendered
and did not validly withdraw their Notes at or prior to 5:00 p.m., New York City Time, on June 22, 2020 (such date and time, as
it may be extended with respect to a Tender Offer, the &ldquo;Early Tender Time&rdquo;) are eligible to receive the Total Consideration
for such Notes accepted for purchase. Holders of the Notes will also receive accrued and unpaid interest on their Notes validly
tendered and accepted for purchase from the last interest payment date up to, but not including, the settlement date. Withdrawal
rights for the Notes expired at 5:00 p.m., New York City Time, on June 22, 2020. On June 24, 2020, Healthpeak expects to pay for
the Notes that were validly tendered prior to or at the Early Tender Time and that are accepted for purchase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Because the aggregate principal amount of
the Notes validly tendered and not validly withdrawn exceeds the Aggregate Maximum Tender Amount, Healthpeak will not accept for
purchase all of the Notes that have been validly tendered and not validly withdrawn and will only accept for purchase the Aggregate
Maximum Tender Amount of those Notes. Accordingly, the Notes validly tendered and not validly withdrawn will be subject to proration.
The Company will use a proration rate of approximately 95% for the Notes. The Notes tendered by a holder will be multiplied by
the proration rate and then rounded down to the nearest $1,000 increment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Since the Tender Offer for the Notes was
fully subscribed as of the Early Tender Time, Healthpeak will not accept for purchase any Notes validly tendered after the Early
Tender Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><IMG SRC="tm2023139d1_ex99-2img001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Information Relating to the Tender Offer</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Wells Fargo Securities and Barclays are
serving as the dealer managers for the Tender Offer. Investors with questions regarding the Tender Offer may contact Wells Fargo
Securities at (704) 410-4759 (collect) or (866) 309-6316 (toll-free) or Barclays at (212) 528-7581 (collect) or (800) 438-3242
(toll-free).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">None of Healthpeak or its affiliates, their
respective boards of directors, the dealer managers, the tender and information agent or the trustee with respect to the Notes
is making any recommendation as to whether holders should tender any Notes in response to the Tender Offer, and neither Healthpeak
nor any such other person has authorized any person to make any such recommendation. Holders must make their own decision as to
whether to tender any of their Notes, and, if so, the principal amount of Notes to tender.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This press release is for informational
purposes only and is not an offer to buy, or the solicitation of an offer to sell, any of the Notes and the Tender Offer does
not constitute an offer to buy or the solicitation of an offer to sell the Notes in any jurisdiction or in any circumstances in
which such offer or solicitation are unlawful. The full details of the Tender Offer are included in the Offer to Purchase. Holders
are strongly encouraged to carefully read the Offer to Purchase, including materials incorporated by reference therein, because
they contain important information. The Offer to Purchase may be downloaded from Global Bondholder Services Corporation&rsquo;s
website at <U>www.gbsc-usa.com/healthpeak/</U> or obtained from Global Bondholder Services Corporation, free of charge, by calling
toll-free at (866) 470-4500 (bankers and brokers can call collect at (212) 430-3774).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Healthpeak</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Healthpeak Properties, Inc. is a fully integrated
real estate investment trust (REIT) and S&amp;P 500 company. Healthpeak owns and develops high-quality real estate in the three
private-pay healthcare asset classes of Life Science, Senior Housing and Medical Office, designed to provide stability through
the inevitable industry cycles. At Healthpeak, we pair our deep understanding of the healthcare real estate market with a strong
vision for long-term growth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This press release contains forward-looking
statements within the meaning of federal securities laws and regulations. These forward-looking statements are identified by their
use of terms and phrases such as &ldquo;believe,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;project,&rdquo; &ldquo;anticipate,&rdquo;
&ldquo;position,&rdquo; and other similar terms and phrases, including references to assumptions and forecasts of future results.
Forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other
factors which may cause the actual results to differ materially from those anticipated at the time the forward-looking statements
are made. These risks and uncertainties include, but are not limited to, Healthpeak&rsquo;s ability to complete the Tender Offer
and reduce its outstanding debt within expected time-frames or at all, and other risks and uncertainties described in the Offer
to Purchase and in its Securities and Exchange Commission filings. Although Healthpeak believes the expectations reflected in such
forward-looking statements are based upon reasonable assumptions, Healthpeak can give no assurance that the expectations will be
attained or that any deviation will not be material. All information in this release is as of the date of this release, and Healthpeak
undertakes no obligation to update any forward-looking statement to conform the statement to actual results or changes in its expectations,
except as required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2023139d1_ex99-2img001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Contact</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Barbat
Rodgers&nbsp;</FONT><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Senior
Director &ndash; Investor Relations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">(949) 407-0400</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>hcp-20200623.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.3c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +K85w7xRiXgen8uNbXAsWaiB6bPtzp5x2ekhuWh5bSmK/y8gHcYs1ywbu7IGwUQI -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:hcp="http://hcpi.com/20200623" elementFormDefault="qualified" targetNamespace="http://hcpi.com/20200623">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://hcpi.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="hcp-20200623_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="hcp-20200623_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>hcp-20200623_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.3c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>hcp-20200623_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.3c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://hcpi.com/role/Cover" xlink:href="hcp-20200623.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://hcpi.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>tm2023139d1_ex5-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2023139d1_ex5-1img001.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "R . # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^Z/XI?&'X
M5_!3P[-XQ^,'Q%\#?"[PA!>?8;GQ5\0_%_A[P3X=LS)I^K:NSWGB+Q?JFA:5
M8@V>BZI>!3?L3;:3-) &6)Q#\U^$O^"E?_!/OXAR7=I\/_VX/V1/&]_IMH+_
M %:S\(_M+?!'Q9=:7IH4EM1OK;0?B+=26%DJAF-Z[%-HW,[$9J7_ (*9?\HY
M?^"@?_9DO[5__JAO&U?P??\ !DQ_R>W^UWYF=O\ PRGIF.G3_A;_ (/VY[XZ
M_A[8H _T(_A#^TO^SI\?8M5'P)^/_P &OC9'H$OEZR_PE^*?@7XE-H]S&2DU
MIJK>'/$GB&>RN() T4\5W#;3Q2JT9C$BM'7O<$PE7(YQT(Z$>OW5Z_[J_P"Z
M.E?YB_\ P<I/XM_9]_X+U^!/'G[&#:EX3_:*\7_#+]G[QE8CX6A;'Q+X@^.W
MBCQ=XL\$Z?!<6.DR6]YJGB/QAX>\/_#W1KG1I4GG\0VNHC59E<7#F;_3/TJZ
MNO[(L+O68K;3]0;3X[C688+AX]/L+I(5>_\ ])GV2O'%/O03S .\:^9*$PQH
M Z"O&_B_\<?A-\!O#,WC7XR?$'P7\,_!ENVJ&[\4?$#Q?X;\&>'[,Z3I.I^(
M+A[G6?&.KZ!IUJJ:?I.K7JRB\:%8-,9DDC0!DZ'PQ\2OA_XQOM6TSPCXY\'^
M*;[0F_XJ#3O#7B?1M:NO#[%G*?VE::=+)?6D]Q("L\%XJ2QSEXF^;[WQK_P5
M=DBG_P""6_\ P4I9?OQ_L ?MG(V 5PZ_LZ>/PXVMA@!\H 8!N,$ YH Z[X _
MM[?LI?M5>)/C-X?^ 'QF^&WQ:TGX'Z)X USXB>-_AY\2_AG\1O FDV'Q(_X6
M#%HYA\1^"O&7BC3;6ZB@\ Z[+JJZC]GD 4HT+DRM'QLO_!4/]A^3XG^!/@;X
M=_:5^"_Q!^,'Q \=:3\.--^&W@/XR?!?Q+\0;;Q+K4LRP?VGX+7Q_I/BA--@
MC@_?7EGX:O9$B9&^SLQVO_(W_P &.2^;;?\ !4 'JUQ^Q?\ S_:J/]/I^%?!
MGB@8_P"#R: #H/V[/"8_+X6:&* /].6-B\:,1@LBL1C&"5!(QEL8STW''3)Z
MT^L.^U#3+"&\O]2N[+3K'35EN;V\O9[&"QLXXRQ-S<W<Q46ORC<[2LI3)R3C
M=6'X6\<^!O&ME+K'@[QCX:\76$<K6<^H^&-=T?7;6"=6,;6EQ>:3)/)!-$X*
M/'*RRQ,/GPP- '<45566)553+@JH!'FM)@@ $>8XWR8/\;?,WWFY)KR?Q;\<
M/@MX(T'5_&7CKXN_#?P=X-T+Q'_PAFM>+/%GCGPMX=\*Z-XN2\-DOA35M8U[
M6K32(O$CZDJV4>CJT>L)?)]B>))RT= 'L5?./QB_:L_9H_9V-X_QX^/GP4^"
M\=I!IVHSR_%3XG^"?APD>DZ_J%QI6FW:WOC76?#UILO]<MIX5;[4\>\$[R&C
MQ[HFK::VF1ZL-1L)-):P35!JOVN%M+>QFB%Q'J"ZHDCVB6\L#K<1S1S20^2Z
MR12-$5D/\_'_  <F>,O!7CC_ ((8?MTZIX1\3^'?%-G9CX#Z;<WWAK6=(UV&
M"\@_:J^!,,MG<WR/+]DFCD7RYD#%T(^8EL  'ZS_ +*G[9'P*_;,\/?$/QM^
MSYXNTKXB>#/AM\5]1^$FJ^,_#'B;P?XV\':UXITOPKX8\4W0\(>)/ GBWQEH
MU[:0:/X]\-L]\][I[7"W+2FU@MVW)]827,<4 N&4F)5WNVY',0P"=Q1G5BO0
ME689'#'.:_D/_P"#+Y=O_!+;XXJ,87]O#XB+PZR#CX(_LU#B1/DD'HZ?*_WE
MX(K]G?\ @MG\;O'W[.__  2P_;<^+7PPO;C1_B!X?^#&H:%X;U^PF%EJ^@_\
M)YK6B> =2\3:3<!PYO\ PMI?C*?5]!9.?^$GT_3@RKN5J /9?&7_  4+^ OA
M[Q[K_P /O!(\3_'GQ)X)O[K3?B?8_L_OX3^*$WP=UJVO'LFTGXM0:1XQMI_A
M[<@6]S<ZC9^([>UN-/:&5-1@@NHVCB]O\,_M'? KQQI_@;4_#GQ6^'_B"R^)
MOBO5?AQX#_L_QMX,UF+Q1XZTCPQJWC7Q1\.](;3_ !!<6>K^+= \.>$_$%[X
MB\/Q&[U?0X_#7B5+J0?9F>OY]?\ @WX_X*A?\$TO%'["/[+?[+/A#XX?"[X0
M_M!>!OAWX;\&_$3X1?$:\T[X>>(?&/Q<N8[J/QOXG\-:GKR^']%^)U_\4_$]
MOK7C)1X6\0ZUXC$NJ12^(+&&\%RK_4'[6?\ P3J?Q#_P6%_X)K?\%%?A-X'M
M9M4\!:]\<?AS^U-?Z18:19:E?>%?%'[,?Q<L/@W\0/&E[$2;N'2/%4-[\+M0
M\3J+F6]TCQ9X%\(0"*U\&11@ _>Z#'D0X+,/*CPS^9N8;!@MYS/-N(Y/FN\F
M<^8S-DF6N0\0>*O#_A71+GQ)XFUO3M#T"S6*2ZUO7)HK#2X(9+FVLEBNYW>*
M#[1=W4Q%GA,/)*@C1A\DD#^-O!D?B>/P+)XM\.KXPN;+[?#X2F\0:7)XJ?3X
MV)2\C\/-,]ZU@T8\Q=0DA(=2K.[, 0 =M151+NV959;A65E#*P*L"" 0054J
M01R"I*D<@XQ7#WOQ,^'>G^+;;P5?^/\ P=IWC"ZA2XM/"=]XFT6Q\47EO,=P
MF@T2_N(]4N;23<&CELHBNS'E;EVX -KQ5XIT'P7H>H>)O%FN:7X:\/Z5%+<Z
MEK6M:K8:7HNGVL98FYU#4]5:&WM$5 6?Y]J$%1N !/QEX!_X*/\ [%OQ>^-W
M@_\ 9^^#7[2?P/\ C5\5/%J^,91X:^$WQA^&'C_4_#R>"M)U76-4/C'0/"GB
MK5M=T;[/'I$J0M>:1:7D<YC2YM;1Q+$?N=O*E1(#(H8!96"Y &+B-CC=S@.-
MHW<X(+5_F-?\$%I!_P 1/_QBP<J?B=_P4! .?O!M6^(&#^( ^M '^GC$0T<9
M#;@40AMV_<"H(;<0"V1SN(&[K@9Q3ZX*U\=^"[KQ)>^"[;Q9X>N?&.GVMM?:
MGX4M]8TRX\26UC.!]FN;G1?-^TVUH497%S+$%"#]ZV_D=BMY9A5#7$!( !/F
M(V3CD[@ &R>X !Z@#I0!<HKQ7QA\<O@MX%\+:OX]\;?%_P"&'@WP3HWB*[\*
MZGXO\7>/O"FA^$]'\9:;JDNCR^%M3U[7==M](L/$;:I$^G?V$&M]7M;Z*2SF
MA2Y A/KUC=V6H6-I>:==07VGWEK;W5C>VMREY;7EG<1)-:W=M>1R2QW<%Q"R
M30W*2R)/&ZRJ[JX8@'Q/_P %,O\ E'+_ ,% _P#LR7]J_P#]4-XVK_/_ /\
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MLKC_ (2KXV?&'QOY,$T8!&F1>+?B/J=MH]Y&IPFIZ#*M_O DCG=L.0#V&BO
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M@UZ_6=;>&2XU^QT%F@MXXVB8 [3P7^VA^R_X_P##OB+QMX+^-G@+Q#X-\*^
M_#WQ2UWQ?I.N9\)#X?>+;OQ!IWAKQ9I/B.Y%KX<U[PUK.M>#?&7AFWUC3YO[
M.LO%GA3Q+HFH"TUP30+:U_\ ;)_9P\%Z)H/B3Q3\5O#.E6GBOXB>(OA#H*7D
M5]I6KZM\4O">CZ]K7BGP$^CZ@8M2T_Q;:Z-X,U[4X-(U5(+^UT[0YHKEEEB(
M?X-\,_\ !'WP'H_[/GPU_9\U'XT^,=5T+X1_!;X!_"SPQK]CX7AT[Q!<^)_V
M8OV@K+X__![QMK]O<:GK6FZU80>)[/3[+QKX.U[0=6L==T=H[W0]<\-LJS1_
M6.E_L<VFE?$'PM\3C\0-0F\7Z3^U;XB_:Z\:IIWAV:WT3QAXIU3]EOQA^R'%
MX:T30;S5]5?P=H-I\/?$%EK=L\FK:YJ7B7QYH]WXAN[N=KVZF< ^BO!7QL^&
M_P 1/$&M>&_ GC#1?$&IZ L]U>?V;<B>"[M[+Q%?>%-3O='9!<Q:IHFF>*O#
M/BCP5K^L6[3)X9\0Z9-HDFV55W>5_M*_M)Q?LW:Y\"9]<\)6_B#P%\7OC;X6
M^"7BOQ8OB=M(N/AM>>-],\3V_@CQ5?\ AV3PWJL/B?PMJ_CZ+PA\/M<N5\0:
M-%X8O/&4?C"ZC72-#\2-#\]^!OV,OB9^SW\)X?A[\#OB]X;7Q%X=UGX=>&?
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MMMXBU[QA=^#_  [X.L=:^"VOW?POUOP3XLTS5?%DOC0 ^I-<^._PKL/%>K^
M+7QGHNN_$S0_ .K?$;_A5VA7>E:I\0-2\':6NBG6-1LO#4+"[U:%;[7_  GI
MU[IUN5D6X\:>&)2ZW7B?PCYOG?[)G[36G_M/^$-9\9Z3I-AIFB6%[X-&EZUH
MGBZ/QUX6\2:7XV^$O@/XP17^E>+X_#VCVMSJ6B6WCQ?!^N:1:ZA?PZ+>:3=K
M]ON@D;R5?%WP,^)_B3XW:O\ $:W^)/A'0O#L_P ,M7^%OAO2[;X8WT_Q7^'N
MG>,;<ZKXK\0>#/BU=_%:/PCI^N:[XRT#X<>(_$,-W\*/$?\ 97ACX5^$_#_A
M^V@N;A?$)X_]G?\ 9@\4_LX^'+WP[X'\4^!+:P\3?%?1_&GCO0HOA_XFM?#U
MSX?_ .%,^$OAKXU?X<^'KCXM7UOX/\=?$3XA>$T^)VN>*?$VG>+-/U7Q7KWC
MR/Q5X=\6>+?%M_\ &+5 #L/B'^V?\%_!G@37?&?@SQ-IOQHU2Q\:Z9\+M!^'
MWPH\3>$?$?B[QA\6M0M]6DB^&FC:EKWCOPQX.L-=&D:!KWB/6M2\6>+/"OAG
MP'X:\/\ BKQO\0-5T30_#WB#5]*]0L_CAX1TK4/ G@?XB>,? /@[XM>.=)BN
M='^&\'C?2_$&M7T$LUX9]6T"&'3-+U77](LK*U66\UU_"6BZ# HE<W5K;%V3
M\^/A[^Q%\2LVLNM^*K6+X=_#3]L3QA\</V8/@M\2]/N?B?HO@'X&^*/V9]1^
M NJ?!77)?^$AODM-/?QAX^^(_P 8_ACI36_BM/AYX/U?2?!<\-ND)T3P%9T[
M]@OQ#X,\:_LU>#OAGXOU[PW\*O!GP9^,?PA_:;U/3[[^S_"WQ:^"_C[P]XWD
M^'7PM\*>"GU[66\+:G\*/BWXVE\5?![6UT^ZB^'?PGT/6/A=_P )'XC_ .$C
MDTJ( _1;X?\ QR^%/Q4N[NS^'OQ#\+^++FQLM/UHV6CZC:W\T^AZZ?)T#Q!:
MI'+.VK^'=2DBFN=.\3:/<S:/JMNT-W8WES;74,S^S1$-'&P.040@_/R"H.?G
MR_/7Y_G_ +W.:^)?A!^SW\1/#?C/P1XV^)GCSPIXUO\ X2_!+Q#\"? T/A3P
M+K7@^"]TCQ?J'PSU/QGX@\5+?^.O%UOJ5UJEU\(O D^F>'[.(V?A>)?%5C;W
M>N1Z_:Z5X-^VU&U54EF*J!N8@LV!C+$  L>I( &<X H =1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 >>^+_ !SX5\$?V3+XO\3^'?#2^)?%.E^#
M_#/_  D>OZ9H4?B'Q;KD@70/#6BC6IH8KWQ5JSVMQ#X;T.W?.JW-K=7D:,S
MKY]_PT1\!9AX/ND^-GPEFM_B&;>W^']Q;_$_P3-;^/)KC4AHL \#BWU^./Q;
M)J&MW-SH5M);1ND&N6-X?*PBHR?M-_!Z+X[?!SQ/\/+;Q+-X+\2O>>&/&OP_
M\<V6D+XEO/ 7Q/\ A;XNT;XD?#+QRGAV21%\3KX0^(/AOPSK;>%I&BAUU;5M
M#DE2'4'>/XMT;_@G#:^$?@M\;O@KHWQ>US3M+\5>/=!\:_LV>)'\.6FK:O\
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M#$HI) P"2 20-SX!Z@;WP.-S=2 .HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
-BB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>tm2023139d1_ex99-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2023139d1_ex99-1img001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  \ -D# 2(  A$! Q$!_\0
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M=>/?ACXF^ _C3>&_M_PFNZ!9,YWO"54YSW5-W^U7U.GQA_;RC4*OPS\'JH&
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MGTW3UUS5)+U--M696:&W#_<4E$SG)PH&>*]9HH **** "BBB@ HHHH ****
'"BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>tm2023139d1_ex99-2img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2023139d1_ex99-2img001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  \ -D# 2(  A$! Q$!_\0
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M=>/?ACXF^ _C3>&_M_PFNZ!9,YWO"54YSW5-W^U7U.GQA_;RC4*OPS\'JH&
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MGTW3UUS5)+U--M696:&W#_<4E$SG)PH&>*]9HH **** "BBB@ HHHH ****
'"BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6610597776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 23, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 23,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-08895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Healthpeak Properties, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000765880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0091377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1920 Main Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Irvine<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92614<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">407-0700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $1.00 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PEAK<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2023139d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2023139d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hcp-20200623_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hcp-20200623_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "hcp-20200623.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "hcp",
   "nsuri": "http://hcpi.com/20200623",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2023139d1_8k.htm",
      "contextRef": "From2020-06-22to2020-06-23",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://hcpi.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2023139d1_8k.htm",
      "contextRef": "From2020-06-22to2020-06-23",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The start date of the period covered in the document, in CCYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r11": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r13": {
   "Name": "Forms 10-K, 20-F, 40-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d-1"
  },
  "r14": {
   "Name": "Forms 20-F, 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220 and 240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001104659-20-076057-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-20-076057-xbrl.zip
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M)5(;*.X)YSSL0M@_@/NC-#;!S.DN)F8GL)N)G+>'B8V7<Y$+LX[D%GC&WM;
MQJM^S3$D^Q<2"0^MR2-O=+/ZO["_G41K#S\++SRPFC@A(I7$$BYK+=AVK3+/
MO$V)KE=JKE?\PS>:V<_(WBX6FH^I6%H]<8=]M%/7SA/S!SQ3V;E?EK\\MFJ5
MG)2VB?L6>4/'%G_*[.EC?;\V2"H)R[]02P,$%     @ AX+74 ]7.X7]"@
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M*'ELHTU\^#WW\58_J'E@_CLHAH)'R6,;+.)C+Z]#M_I.JR=>+=-J8G]0 AH
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M60;L8:X4K19E;ZY,U?M+8MQ#):#X$2<OXV915]!9YGO.G]A[8LFJG[$HA$I
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MD6EXO*%["-85U-+RF\B5HA!UPFL*(3HC<2A2MQ6 L+R:P0O:?]SCV-B1IMV
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MRNV=NE9L[DLW[0^'S7?O!$O^'U!+ P04    " "'@M=0'"7!A_5+  #T[@$
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M$\>@?<*CM!?ZL@40 VY(4QHQK-B_/1BU ;^?ZD0#2YH W5%CC$O5X\T2$&0
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MN^?/, H7_:?-QH$&]1*; 1BBA^ "ZI41M<I@:OHCQ,>HGD$2SW227; .4F>
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M!42Y,$:E+W5CE# RST'F4J%HOENKT!AX3<,#L"0X,U*4R+B0A^&E$BK&7#M
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MS/%VS(Q'LJ!]O^BAAI"B:'D*'<4^/H$TFZ%E2Q<]7[W+TX RV_:QDH_D7$>
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M$M\YB:U2^T$RWZB9H73T-B6MYUH\%PRER-!S5\.=HR6/F:J<T48$>'[Y8=M
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M4HK/37)[S, OEU_5O9X<Y:R4,HB6?[>:47WO:&BR-*YZ 1,O;IJX? <1DQ4
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ML+;%P:NG/LUL T\2N"+PA1.ME5"4!4<&9PA8OD\<[<:G78IX*J54#X'+GR0
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M-MZ!PD#Y7EE<K89(2B!N\?@E<8>U3,MU U?*(E9H0Z'+29!C18JDR<JU-7V
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M;#,;"_8X"C_GR1Y Z#B9I#R>(S >*WKXI,- ) 1)'(N 6LQD-F;8*LT'D0Q
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M11X++&0[.Z[Y>'1^^6NW46@+YO%^3\7\D*Y-"X6XUEP[37G\EHU!CBY2F8"
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MQ*;**H1Q1$L4$@&0_*9&_J.R*A&QU$UUM\;W.G-4Y 'HOJ&2J/+YF.@QK_O
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M:T?TX)"]\(.&*XZ*XR_3(/U2;<H>;7SX8_8]^DK>?C9OOZ[_+U!+ P04
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M#?[%F_\"4$L! A0#%     @ AX+74*7<E/I  P  @ P  !
M ( !     &AC<"TR,#(P,#8R,RYX<V102P$"% ,4    " "'@M=0#U<[A?T*
M  #?AP  %               @ %N P  :&-P+3(P,C P-C(S7VQA8BYX;6Q0
M2P$"% ,4    " "'@M=0].,8M5,'   K60  %               @ &=#@
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M,3,Y9#%?97@U+3(N:'1M4$L! A0#%     @ AX+74"@9F]Y $   9C\  !4
M             ( !6Z   '1M,C R,S$S.60Q7V5X."TQ+FAT;5!+ 0(4 Q0
M   ( (>"UU#:!>UX$P\  *5$   6              "  <ZP  !T;3(P,C,Q
M,SED,5]E>#DY+3$N:'1M4$L! A0#%     @ AX+74 _/8"I6#P  ^$8  !8
M             ( !%<   '1M,C R,S$S.60Q7V5X.3DM,BYH=&U02P4&
/  H "@"6 @  G\\

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2023139d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hcpi.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2023139d1_8k.htm">tm2023139d1_8k.htm</File>
    <File>hcp-20200623.xsd</File>
    <File>hcp-20200623_lab.xml</File>
    <File>hcp-20200623_pre.xml</File>
    <File>tm2023139d1_ex4-1.htm</File>
    <File>tm2023139d1_ex5-1.htm</File>
    <File>tm2023139d1_ex5-2.htm</File>
    <File>tm2023139d1_ex8-1.htm</File>
    <File>tm2023139d1_ex99-1.htm</File>
    <File>tm2023139d1_ex99-2.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>21
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M53-*\@9-#;3HH'D3&B^XG%JO.8LA\8SO'T:/8NG!F(5@[^Z5=.*/',/WS'\
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M]_276<]>@C"MA[_)1/TUP.K795]02P,$%     @ AX+74 N/V ,A 0  5P0
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M<F5L<R\N<F5L<U!+ 0(4 Q0    ( (>"UU GZ(<.@@   +$    0
M      "  >D   !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ AX+74(J/
M:V;M    *P(  !$              ( !F0$  &1O8U!R;W!S+V-O<F4N>&UL
M4$L! A0#%     @ AX+74)E<G",0!@  G"<  !,              ( !M0(
M 'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " "'@M=0#2"]1JD"  #Y
M"P  &               @ 'V"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
M4$L! A0#%     @ AX+74'[QJ-14 @  )08  !0              ( !U0L
M 'AL+W-H87)E9%-T<FEN9W,N>&UL4$L! A0#%     @ AX+74+JA.8K7 0
M,@8   T              ( !6PX  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M" "'@M=0, /WOC<!   B @  #P              @ %=$   >&PO=V]R:V)O
M;VLN>&UL4$L! A0#%     @ AX+74/_ )@B]    A0(  !H
M ( !P1$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @
MAX+74 N/V ,A 0  5P0  !,              ( !MA(  %M#;VYT96YT7U1Y
><&5S72YX;6Q02P4&      H "@"  @  "!0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>tm2023139d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hcp-20200623.xsd" xlink:type="simple"/>
    <context id="From2020-06-22to2020-06-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
        </entity>
        <period>
            <startDate>2020-06-22</startDate>
            <endDate>2020-06-23</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2020-06-22to2020-06-23">0000765880</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2020-06-22to2020-06-23">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2020-06-22to2020-06-23">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2020-06-22to2020-06-23">2020-06-23</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2020-06-22to2020-06-23">Healthpeak Properties, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2020-06-22to2020-06-23">MD</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2020-06-22to2020-06-23">001-08895</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2020-06-22to2020-06-23">33-0091377</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2020-06-22to2020-06-23">1920 Main Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2020-06-22to2020-06-23">Suite 1200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2020-06-22to2020-06-23">Irvine</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2020-06-22to2020-06-23">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2020-06-22to2020-06-23">92614</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2020-06-22to2020-06-23">949</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2020-06-22to2020-06-23">407-0700</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2020-06-22to2020-06-23">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2020-06-22to2020-06-23">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2020-06-22to2020-06-23">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2020-06-22to2020-06-23">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2020-06-22to2020-06-23">Common stock, $1.00 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2020-06-22to2020-06-23">PEAK</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2020-06-22to2020-06-23">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2020-06-22to2020-06-23">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
